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EXPLANATION OF DISSERTATION FORMAT 
The alternative format was used in writing this dissertation. The 
first manuscript has been accepted for publication in Molecular Immunology. 
The second manuscript has been accepted for publication in Veterinary 
Immunology and Immunopathology. The third manuscript will likely be 
submitted to Immunology. The format used for this dissertation is that of 
Veterinary Immunology and Immunopathology. Literature cited in the General 
Introduction and General Summary and Discussion is listed at the end of the 
dissertation. 
The candidate, Brad Bosworth, was the principal investigator for each 
of the studies. The coauthors of the first manuscript, Drs. Gallatin and 
St. John provided advice, reagents, and minor assistance in the writing of 
the manuscript. Dr. Harp, coauthor on all three manuscripts, provided 
advice and assistance in the studies and assisted in the writing of the 
manuscripts. Dr. Jutila kindly provided the antibody DREG-56 and Don 
Dowbenko provided one of the LECAM-1 cDNA clones used in the third 
manuscript. 
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GENERAL INTRODUCTION 
Introduction 
Infectious diseases in cattle are costly to the agricultural industry 
because of decreased productivity, cost of prevention and treatment of 
infectious diseases, and losses due to culling and death. The bovine immune 
system is important in mediating resistance to infectious diseases. The 
immune system involves a variety of cell types and soluble effector 
molecules which afford host protection against pathogenic organisms. The 
B and T lymphocytes are an integral part of the immune system because they 
are responsible for antigen recognition by the immune system and allow 
establishment of antigen-specific memory. Antigen-specific memory allows 
a more efficient immune response upon subsequent exposure to the same 
infectious agent (Tonegawa, 1985). 
One interesting aspect of the immune system is a partial separation of 
the lymphocyte populations in mucosal organs (i.e.; intestine, respiratory 
tract, and reproductive organs) from that in peripheral organs. The basis 
for these somewhat separate lymphocyte populations is the preferential 
recirculation or homing of lymphocytes to either peripheral lymph nodes or 
mucosal lymphoid tissue (Gowans and Knight, 1964; Gahill et al., 1977; 
Scollay et al., 1976; Rose et al., 1976; Harp et al., 1988). Thus, the 
available repertoire of antigen-specific lymphocytes in mucosal lymphoid 
tissue is somewhat distinct from that in peripheral lymph nodes. 
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Mucosal immunity in non-ruminants 
The major site of antigen uptake in the gut-associated lymphoid tissue 
is the Peyer's patch (Owen and Nemanic, 1978). The Peyer's patch consists 
of lymphoid aggregates in the intestinal wall covered by a layer of cuboidal 
epithelial cells on the lumenal surface. Specialized membrane epithelial 
cells (M cells) are present within the cuboidal epithelial cells that are 
involved in transporting foreign antigens into the Peyer's patches. 
Specialized epithelial cells similar in function to Peyer's patch M cells 
are also present in the bronchus-associated lymphoid tissue of the 
respiratory tract (Sheldrake and Husband, 1985). 
After transport into the Peyer's patch, antigens are phagocytized by 
macrophages that travel to the lymphoid rich region of the Peyer's patch 
(Richman et al., 1981) and then initiate an immune response by presenting 
antigen to lymphocytes. After recognizing antigen and differentiating in 
the Peyer's patch, lymphocytes can enter the intestinal lymphatics, pass 
through mesenteric lymph nodes, enter the thoracic duct and then pass into 
the systemic circulation (Jalkanen, 1990). These lymphocytes recirculate 
through the blood and cxtravasate at mucosal sites. In the rodent, these 
mucosal sites include the Peyer's patches (McDermott and Bienenstock, 1979), 
lamina propria (Jeurissen et al., 1987), genital organs, respiratory tract 
(McDermott and Bienenstock, 1979), and mammary gland (Roux et al., 1977; 
Bienenstock et al., 1978). 
The mucosal immune system of non-ruminants has unique characteristics 
that differentiate it from the peripheral immune system. Mucosal 
immunization results in local IgA production and parental immunization 
results in serum IgG (Tomasi et al., 1980), The predominant isotype present 
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in mucosal secretions of non-ruminants is IgA. Most of this IgA is produced 
locally by lymphocytes in the lamina propria of the intestine, the 
respiratory tract and other mucosal organs of non-ruminants (Tomasi et al., 
1980). 
In non-ruminants, not all of the IgA present in intestinal secretions 
is directly derived from local production by lymphocytes in the lamina 
propria. Some of the IgA produced by lymphocytes in the lamina propria 
escapes into the blood. This blood-borne IgA is transported into the bile. 
Bile is therefore rich in IgA and is another route by which IgA reaches the 
intestinal lumen in some non-ruminant species (Tizard, 1982). 
Lymphocytes in Peyer's patches, lamina propria, reproductive tract, 
respiratory tract, and mammary gland are derived from the same recirculating 
pool of lymphocytes in non-ruminants (Roux et al. , 1977; Bienenstock et al. , 
1978; McDermott and Bienenstock, 1979; Jeurissen et al., 1987). Therefore, 
the antigen-specificity of lymphocytes and the antibody isotype present in 
these mucosal organs are somewhat similar and these organs are said to be 
part of a "common mucosal immune system" in non-ruminants. 
Mucosal immunity In ruminants 
The mucosal immune systems of cattle and sheep are markedly different 
from non-ruminants and care must be exercised when extrapolating information 
from non-ruminants to cattle and sheep. In cattle and sheep, intestinal 
fluids contain equal amounts of IgG^ and IgA (Lascelles et al., 1986). A 
majority of sheep intestinal IgG^ is derived from serum (Cripps et al., 
1974), even though a large number of IgGi+ lymphocytes are present in the 
lamina propria (Lascelles et al., 1986). Data from experiments using 
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intravenous injections of radioisotope-labeled IgA suggest that sheep 
intestinal IgA is primarily produced locally (Cripps et al., 1974). In 
certain situations, some of sheep intestinal IgA may be derived from bile. 
Injection of antigen into the intestinal wall resulted in antigen-specific 
IgA in the bile that was likely derived by active transport from the blood 
(Hall, 1986). 
In cattle and sheep, secretions in the upper respiratory tract are 
composed of equal amounts of IgG^ and IgA (Lascelles et al., 1986). The 
majority of IgG^ in sheep was derived from serum while the bulk of IgA 
present in upper respiratory secretions is produced locally (Scicchitano, 
1984a). The similarities in the isotypes of antibodies in the intestine and 
upper respiratory tract suggest that these tissues may be part of the common 
mucosal immune system in ruminants. There is evidence to support this 
hypothesis, at least in sheep. Intestinal immunization resulted in the 
homing of antigen-specific lymphocytes to the upper respiratory tract of 
sheep (Scicchitano, 1984b). Therefore, the intestinal immune system 
contributes to upper respiratory immunity in sheep, via the homing of 
lymphocytes from the intestine to the upper respiratory system. 
The predominant isotype of secretions in the lower respiratory tract 
(broncho-alveolar secretions) of sheep and cattle is IgG^ (Lascelles et al. , 
1986). It is not known whether this IgG^ is produced locally of derived 
from serum. The lower respiratory tract of sheep does not appear to be part 
of a common mucosal immune system as lymphocytes sensitized to antigen in 
the intestine do not home to the regional lymph nodes draining the lower 
respiratory tract (Scicchitano, 1984b). 
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Mammary inununltv in ruminants 
The mammary immune system of cattle and sheep is quite different from 
that of other species. IgG^ is the most predominant isotype in milk and 
colostrum in cattle. The concentrations of IgG^ and IgA in milk are 0.40 
mg/ml and 0.11 mg/ml, respectively. The concentrations of IgG^ and IgA in 
colostrum are 48.2 mg/ml and 4.70 mg/ml, respectively (Lascelles et al., 
1986). Colostral IgG^ is derived primarily from serum shortly before 
parturition (Brandon et al., 1971), but there is evidence that IgG^ can be 
produced locally during intramammary infection (Chang et al., 1981). The 
small amount of IgA present in milk is produced locally during mammary 
infections (Lascelles et al., 1966). 
The recirculation of lymphocytes to the mammary gland in cattle and 
sheep is quite different from rodents. The mammary gland of rodents is part 
of a common mucosal immune system as lymphocytes from the intestine will 
home to the mammary gland in rodents (Roux et al., 1977). Thus, intestinal 
lymphocytes sensitized to intestinal pathogens can home to the mammary gland 
in rodents, transferring protection against enteric disease to suckling 
offspring via the milk. 
This does not appear to be the case in ruminants. Intestinal 
immunization does not result in any substantial homing of antigen-specific 
lymphocytes from the intestine to the mammary gland of sheep (Sheldrake et 
al., 1985; Sheldrake and Husband, 1985). Studies examining the in vivo 
homing of lymphocytes in cattle demonstrate that intestinal lymph node 
lymphocytes do not readily home to mammary lymph nodes (Harp et al., 1988). 
Lymphocytes from intestinal lymph nodes home primarily to intestinal lymph 
nodes, while tending to avoid homing to both mammary and prescapular lymph 
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nodes (Harp et al., 1988). 
Bovine mammary lymph node lymphocytes tend to avoid homing to 
intestinal lymph nodes in vivo. These lymphocytes preferentially home to 
mammary and prescapular lymph nodes (Harp et al., 1988). The homing of 
mammary lymph node lymphocytes primarily to mammary lymph nodes and 
prescapular lymph nodes suggests that the mammary lymph node is a peripheral 
lymph node, not a mucosal lymph node. Therefore, the mammary immune system 
of cattle and sheep is probably not part of a common mucosal immune system. 
Lymphocyte homing 
The recirculation or homing of blood-borne lymphocytes is well 
documented and was first reported over 25 years ago (Cowans and Knight, 
1964). Studies in rodents, sheep and cattle have demonstrated that this 
recirculation is not random as lymphocytes tend to recirculate or home to 
specific organs or regions of the body. Lymphocytes can recirculate or home 
to either peripheral lymph nodes or mucosal lymphoid tissue (Cahill et al. , 
1977; Harp et al., 1988; Rose et al., 1976). Lymphocyte homing allows 
antigen-specific lymphocytes to extravasate at distant body sites, and it 
facilitates interactions between T and B lymphocytes and other accessory 
cells of the immune system (Miyasaka and Trnka, 1986). 
Recirculating lymphocytes leave the blood and enter the lymph node at 
specialized venules located in the paracortex (Gowans and Knight, 1964). 
In order to extravasate, lymphocytes must first bind to, migrate along and 
then extravasate through the endothelium lining these paracortical venules. 
The initial binding of lymphocytes to the endothelium of paracortical 
venules in the lymph node controls the tissue-specificity of lymphocyte 
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homing. 
In rodents and humans, these paracortical venules are lined with high-
walled endothelium and are therefore termed high-walled endothelial venules 
(HEV) (Gowans and Knight, 1964; Jalkanen and Butcher, 1985; Butcher, 1990). 
In cattle and sheep, the paracortical venules are lined with endothelium 
that is not as "high" as that in HEV of rodents and humans (Harp et al., 
1990). While the paracortical venules in sheep are not lined with high-
walled endothelium, lymphocytes extravasate through these paracortical 
venules in sheep (Harp et al., 1990). 
Homing of B and T cells 
It has been reported that in vivo B cell recirculation is slower than 
T cell recirculation in rodents (Howard, 1972; Sprent, 1976), but not in 
sheep. Sheep B and T lymphocytes recirculate with similar kinetics to 
intestinal and prescapular lymph in vivo (Reynolds et al., 1988). As sheep 
and rodent lymphocytes exit the blood and enter the lymph node primarily 
through the paracortical venules in vivo (Harp et al., 1990; Gowans and 
Knight, 1964), and murine B and T cells bind to paracortical venules in 
vitro (Stevens et al., 1982), it is possible that the molecular mechanisms 
controlling lymphocyte binding to and extravasation through paracortical 
venules are similar for both B and T cells. 
After entry into the lymph node, B cells tend to migrate to follicles 
and germinal centers in the cortex and T cells tend to remain in the 
paracortex. The mechanisms controlling the migration of B and T lymphocytes 
within lymph nodes after extravasation are poorly defined (Jalkanen, 1990). 
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In vitro HEV assay 
Stamper and Woodruff (1976) developed an in vitro HEV assay which 
allows study of the initial adherence event. In this assay, lymphocyte 
suspensions are placed on frozen sections of lymph nodes. The lymphocytes 
adhere specifically to HEV in lymph node sections. Using the in vitro HEV 
assay, it has been shown that the tissue-specificity of in vivo homing to 
either peripheral lymph nodes or to mucosal lymphoid tissue is due to 
receptor-mediated adherence of lymphocytes to HEV in either peripheral lymph 
nodes or mucosal lymphoid tissue. The molecules on lymphocytes that are 
involved in homing are called homing receptors and the HEV molecules are 
termed vascular addressins (Butcher, 1990; Stoolman, 1989). While these 
molecules are involved in the initial tissue-specific adherence, they do not 
mediate lymphocyte homing entirely by themselves. Other molecules (such as 
CD44 and LFA-1) play an accessory role in homing (Chin et al., 1991). 
Using this in vitro HEV assay, some of the bovine, human, and murine 
homing receptors and vascular addressins have been identified and 
characterized (Gallatin et al., 1983; Streeter et al., 1988a, 1988b; 
Kishimoto et al., 1990; Bosworth and Harp, 1991; Bosworth and Harp, Part III 
of this dissertation). While differences exist between cattle and non-
ruminants in paracortical venule morphology, antibody isotype in intestinal 
and mammary secretions, and lymphocyte homing to the mammary gland; some 
molecules controlling lymphocyte homing in cattle are very similar to those 
in mice and humans (Bosworth et al. , 1991; Bosworth and Harp, 1991; Bosworth 
and Harp, Part III of this dissertation). 
Further evidence for the conservation of molecules controlling 
lymphocyte homing in a variety of species comes from studies that 
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demonstrate that the receptor-mediated adherence of lymphocytes to HEV is 
highly conserved across species barriers. Bovine, murine, guinea pig, and 
human lymphocytes adhere in a tissue-specific manner to HEV in sections of 
murine lymphoid tissue in vitro (Wu et al., 1988; Bosworth and Harp, 1991; 
Bosworth and Harp, Part III of this dissertation). The tissue-specific 
pattern of human and guinea pig lymphocyte adherence to murine HEV mimics 
the pattern seen using human and guinea pig lymphocytes and homologous HEV 
(Wu et al. , 1988). The pattern of bovine lymphocyte adherence to murine HEV 
in vitro reflects the in vivo homing patterns of bovine lymphocytes. Bovine 
mammary and prescapular lymph node lymphocytes bind in relatively equal 
numbers to murine peripheral lymph node HEV in vitro (Bosworth and Harp, 
Part III of this dissertation) and bovine mammary lymph node lymphocytes 
tend to home like peripheral lymph node lymphocytes in vivo (Harp et al., 
1988). 
Attempts to duplicate this in vitro HEV assay using bovine or sheep 
lymphocytes on homologous lymph node sections have been unsuccessful 
(Bosworth and Harp, personal observations; Miyasaka and Trnka, 1986). The 
reasons for this lack of success are not known. It may be due to low number 
of available binding sites for lymphocytes in paracortical venules in 
ruminants, since endothelial cells in these venules are not high in sheep 
and cattle (Miyasaka and Trnka, 1986; Harp et al., 1990). 
In the following section of this review, the molecules involved in 
murine and human lymphocyte homing will be discussed. When possible, the 
relevance of similar molecules in cattle will be discussed. 
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Molecular Mechanisms Controlling Lymphocyte Homing 
Mucosal lymphocyte homing receptors 
Antibodies that recognize two distinct murine lymphocyte antigens, 
LPAM-1 and LPAM-2 (lymphocyte Peyer's patch HEV adhesion molecules, 
heterodimers with a common alpha subunit but different beta subunits), block 
the binding of murine lymphocytes to Peyer's patch HEV in vitro (Holzmann 
et al. , 1989; Holzmann and Weissman, 1989). These antibodies have no effect 
on the binding of lymphocytes to peripheral lymph node HEV. This suggests 
that LPAM-1 and LPAM-2 may be mucosal homing receptors in the mouse. 
However, mere expression of LPAM-2 is not sufficient in itself to mediate 
lymphocyte binding to Peyer's patch HEV (Holzmann and Weissman, 1989). 
Possibly, adherence of lymphocytes to Peyer's patch HEV is due to the 
interactions of multiple adhesion receptors. There are no data on the role 
of bovine LPAM-1 or LPAM-2 in bovine lymphocyte homing. 
Peripheral lymphocyte hominp receptors 
The human and murine peripheral lymphocyte homing receptors, recently 
termed LECAM-1 (lectin cell adhesion molecule-1), have been identified and 
characterized. The predicted amino acid sequences of human and murine 
LECAM-1 have a domain that is homologous to a number of calcium-dependent 
animal lectins (Bowen et al., 1989; Lasky et al., 1989; Siegelman et al., 
1989; Siegelman and Weissman, 1989). As specific carbohydrates block the 
binding of human and murine lymphocytes to peripheral lymph node HEV in 
vitro (Stoolman and Rosen, 1983, Stoolman et al., 1984; Stoolman et al., 
1987), the lectin domain of human and murine LECAM-1 is likely involved in 
binding of lymphocytes to peripheral lymph node HEV. Also, the monoclonal 
antibody MEL-14, which blocks the binding of murine lymphocytes to 
peripheral lymph node HEV in vitro and homing of murine lymphocytes to 
peripheral lymph nodes in vivo, recognizes the lectin domain of LECAM-1 
(Bowen et al., 1990). 
Human and murine LECAM-1 also contain a domain with homology to 
proteins in the epidermal growth factor (EGF) family. This domain may have 
a role in lymphocyte homing. A monoclonal antibody that binds to the EGF-
like domain of murine LECAM-1 reduced the binding of murine lymphocytes to 
peripheral lymph node HEV in vitro (Siegelman et al. , 1990). The exact role 
the EGF-like domain plays in HEV binding has been speculated to be due a 
direct role in HEV binding. However, it is possible that the antibody that 
reacted with the EGF-like domain reduced HEV binding due to secondary 
changes induced on the lectin domain of LECAM-1 or due to steric effects of 
the antibody (Siegelman et al. , 1990). Murine and human LECAM-1 contain two 
repeated domains that show homology to a number of proteins, most of which 
have a role in complement-binding (Bowen et al., 1989; Lasky et al., 1989; 
Siegelman et al., 1989; Siegelman and Weissman, 1989). The role of the 
LECAM-1 domains which are similar to complement-binding protein domains in 
lymphocyte homing has not been established. 
The bovine peripheral lymphocyte homing receptor has lectin-like 
activity and is functionally similar to human and murine LECAM-1. Fructose-
1-phosphate and fucoidin, which block the binding of human and murine 
lymphocytes to peripheral lymph node HEV, block the binding of bovine 
lymphocytes to murine peripheral lymph node HEV (Bosworth and Harp, 1991). 
We have recently isolated and sequenced cDNA clones that encode for bovine 
LECAM-1 (Bosworth and Harp, Part III of this dissertation). Bovine LECAM-1 
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has high amino acid sequence identity with human and murine LECAM-1. Bovine 
LECAM-1 contains domains that have high identity with the lectin domain, 
epidermal growth factor-like domain, and two repeated domains similar to 
complement-binding proteins present in human and murine LECAM-1. The 
antibody DREG-56, which recognizes human LECAM-1 and blocks the binding of 
human lymphocytes to peripheral lymph node HEV (Kishimoto et al., 1990), 
blocks the binding of bovine peripheral blood lymphocytes (PBL) to murine 
peripheral lymph node HEV (Bosworth and Harp, Part III of this 
dissertation). The effect of DREG-56 is tissue-specific in that it has no 
effect on the binding of human (Kishimoto et al. , 1990) and bovine 
lymphocytes to Peyer's patch HEV (Bosworth and Harp, Part III of this 
dissertation). These data strongly suggest that bovine LECAM-1, like human 
and murine LECAM-1, is a peripheral lymphocyte homing receptor. 
Differences are seen in the tissue distribution of bovine LECAM-1. Few 
lymphocytes from bovine Peyer's patch express LECAM-1 (Bosworth and Harp, 
Part III of this dissertation), whereas this molecule is present on most 
murine lymphocytes that home to either peripheral lymph nodes or Peyer's 
patches in vivo (Gallatin et al., 1983). Presumably, the LECAM-l"^ 
lymphocytes that home to murine Peyer's patches in vivo express mucosal 
homing receptors; the LECAM-1 present on these Peyer's patch homing 
lymphocytes may be modified and unable to mediate homing to peripheral lymph 
nodes. Thus in the mouse, LECAM-1 is specific in function, but not 
distribution, to peripheral homing lymphocytes (Gallatin et al., 1983), 
whereas in the bovine both function and distribution are specific to 
peripheral homing cells (Bosworth and Harp, Part III of this dissertation). 
The finding that bovine LECAM-1 is present in high amounts on 
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lymphocytes derived from peripheral and mammary lymph nodes, and low amounts 
on lymphocytes derived from Beyer's patch, provides an explanation at the 
molecular level for the previous observation that bovine mammary lymphocytes 
exhibit homing patterns similar to peripheral rather that mucosal 
lymphocytes (Harp et al., 1988). 
In addition to its role in lymphocyte homing, LECAM-1 is involved in 
the binding of neutrophils to endothelium in areas of inflammation (Jutila 
et al., 1989; Kallmann et al., 1991). The antibody MEL-14 which recognizes 
murine LECAM-1, decreases the number of murine neutrophils that are 
recruited to sites of inflammation in vivo (Jutila et al., 1989). It is not 
known if bovine LECAM-1 plays a similar role in bovine neutrophil adherence 
to endothelium. 
Vascular addressins 
Streeter et al. (1988b) have described a monoclonal antibody that 
reacts with murine Peyer's patch HEV but not peripheral lymph node HEV. 
This monoclonal antibody, termed MECA-367, precipitates a 58-67 kD 
endothelial cell protein expressed at mucosal sites of lymphocyte 
extravasation. The monoclonal antibody MECA-367 probably recognizes the 
mucosal vascular addressin because it blocks the binding of murine 
lymphocytes to Peyer's patch HEV in vitro, and lymphocyte homing to Peyer's 
patches in vivo (Streeter et al., 1988b). There are no data on the bovine 
mucosal vascular addressins at this time. However, the bovine and murine 
mucosal vascular addressins may be similar as both bovine and murine 
lymphocytes bind to murine Peyer's patch HEV in vitro (Bosworth and Harp, 
1991). 
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The monoclonal antibody MECA-79 recognizes human and murine peripheral 
lymph node vascular addressins (Butcher, 1990). The antigen detected by 
MECA-79 is expressed at high levels in murine peripheral lymph node HEV 
while its expression in Peyer's patch HEV is more restricted (Streeter et 
al., 1988a). The antibody MECA-79 blocks the binding of murine lymphocytes 
to peripheral lymph node HEV in vitro, and homing of murine lymphocytes to 
peripheral lymph node HEV in vivo, but has no effect on the interaction of 
lymphocytes with Peyer's patch HEV (Streeter et al., 1988a). A soluble 
recombinant form of LECAM-1 reacts selectively with murine peripheral lymph 
node HEV (Imai et al., 1991). The bovine peripheral lymph node vascular 
addressin is probably similar to that of human and mouse because the 
antibody MECA-79 and the soluble recombinant form of LECAM-1 cross react 
with bovine paracortical venules in peripheral lymph nodes (personal 
communication with Bruce Walcheck of Montana State University, Bozeman, MT; 
Mark Singer, University of California, San Francisco, CA). 
Other molecules with an accessory role in Ivmphocvte hominp 
The f i - 2  integrin LFA-1, a heterodimer consisting of CDlla and the 
common P-2 subunit CD18, may have an accessory role in lymphocyte homing. 
Antibodies that recognize LFA-1 partially reduce murine and human lymphocyte 
binding to peripheral lymph node HEV and Peyer's patch HEV in vitro, and 
murine lymphocyte homing to peripheral lymph nodes and Peyer's patches in 
vivo (Hamann et al., 1988; Pals et al., 1988). A calf with a genetic defect 
in the expression of CD18, the P-2 subunit of LFA-1, appears to have some 
lymphocyte homing. Lymphocytes were present in the paracortical areas of 
lymph nodes in this calf (Kehrli et al,, 1990). Possibly, the adhesive 
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functions of LFA-1 may be assumed by other lymphocyte adhesion molecules 
(Springer et al., 1987). 
The glycoprotein CD44, has been reported to be involved in lymphocyte 
homing in humans. The monoclonal antibody Hermes-3 which recognizes CD44, 
blocks the binding of human lymphocytes to Peyer's patch HEV, but does not 
reduce the binding of lymphocytes to peripheral lymph node HEV. While the 
effect of Hermes-3 is limited to mucosal homing lymphocytes, polyclonal 
antibody to CD44 blocks the binding of human lymphocytes to both Peyer's 
patch HEV and peripheral lymph node HEV (Jalkanen et al., 1987). 
Recent evidence has shown that distinct forms of CD44 exist. The 
shorter form of CD44 is present in most hematopoietic cells and has already 
been sequenced in many species, including the bovine (Bosworth et al., 
1991). Longer forms of CD44 containing additional amino acids are present 
in keratinocytes, epithelial cells, a myelomonocytic cell line, and a 
pancreatic carcinoma cell line (Stamenkovic et al., 1991; Gunthert et al., 
1991; Brown et al., 1991; Dougherty et al., 1991). These longer forms are 
likely derived by the addition of exons into the shorter form of CD44 (Brown 
et al., 1991). It has been speculated that glycosylation of the related 
core peptides could possibly be unique for each cell type and reflect 
functional differences of CD44 (Brown et al., 1991). Transfection of cells 
with the cDNA encoding for the shorter hematopoietic form of CD44 allowed 
a B cell line to bind to an endothelial cell line derived from HEV 
(Stamenkovic et al. , 1991). This binding is blocked by polyclonal anti-CD44 
antiserum, but not by Hermes-3. Transfection of the same B cell line with 
a longer form of CD44 did not cause an increase in binding to the cultured 
endothelial cells. Expression of a longer form of CD44, derived from a 
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pancreatic carcinoma cell line, conferred full metastatic behavior to a 
nonmetastasizing cell line (Gunthert et al, 1991). There are no reports on 
the existence of longer forms of bovine CD44. CD44 is clearly more than 
just a homing receptor as it is involved in a wide variety of cellular 
adhesion events and can be best described as a multipurpose adhesion protein 
(Stoolman, 1989). 
Comparison of the predicted amino acid sequences of the shorter forms 
of bovine, human, and murine CD44 shows extensive overall similarities 
between species (Bosworth et al. , 1991). However, there is an extracellular 
region of about 75 amino acids that has considerable variability between 
species. The location of this variable region is conserved between species. 
The antibody Hermes-3, which recognizes human CD44 and blocks the binding 
of human lymphocytes to Peyer's patch HEV (Jalkanen et al., 1987), 
recognizes an epitope of human CD44 that may lie within this variable region 
(Goldstein et al., 1989). While the antibody Hermes-3 cross reacts with 
bovine lymphocytes, it does not reduce the binding of bovine lymphocytes to 
peripheral lymph node HEV or Peyer's patch HEV (Bosworth, personal 
observations). The different effects of Hermes-3 on bovine and human 
lymphocyte binding to HEV may possibly be due to the amino acid differences 
in the variable region. 
Conclusions 
The recent advances in identifying some of the lymphocyte homing 
receptors and vascular addressing in the bovine have increased our 
understanding of the molecular basis of bovine lymphocyte homing. 
The in vitro HEV assay has been used to characterize the molecules 
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controlling the binding of lymphocytes to HEV in lymph node sections in a 
variety of species (Bosworth and Harp, 1991; Bosworth and Harp, Part III of 
this dissertation, Wu et al., 1988; Gallatin et al., 1983). Experiments are 
currently being planned to verify that the binding of bovine lymphocytes to 
murine HEV in vitro represents the events controlling homing in vivo. 
Bovine lymphocytes will be treated with DREG-56 to determine if this 
antibody reduces the homing of bovine lymphocytes to bovine peripheral lymph 
nodes in vivo. Additionally, more research is needed to determine what 
role, if any, bovine CD44 plays in bovine lymphocyte homing. 
The antibody DREG-56, which recognizes a peripheral lymphocyte homing 
receptor, bovine LECAM-1, should prove useful in studying the immune system 
in cattle. High levels of bovine LECAM-1 are present on lymphocytes from 
peripheral lymph nodes, little LECAM-1 is present on lymphocytes from 
Beyer's patches (Bosworth and Harp, Part III of this dissertation). This 
antibody could be used to determine if a lymphoid organ is part of the 
peripheral or mucosal immune system. Since lymphocytes from bovine Peyer's 
patches express little LECAM-1, it would be of interest to determine if 
lymphocytes in the upper respiratory tract and reproductive tract of cattle 
also express low levels of LECAM-1. 
Future research should focus on the in vivo role of these molecules 
that control lymphocyte homing and tissue-specific immunity. These studies 
should further increase our understanding of lymphocyte homing and lay the 
groundwork for future methods that enhance tissue-specific immunity in the 
bovine and other animals. 
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ABSTRACT 
CD44 is a glycoprotein involved in lymphocyte homing to secondary 
lymphoid organs and may function in other intercellular adhesion events as 
well. We have isolated and sequenced a cDNA clone which encodes for bovine 
CD44. The predicted amino acid sequence of bovine CD44 had an overall high 
similarity with that of human and mouse CD44, 79.5% and 73.2%, respectively. 
In all three species, CD44 had a similar transmembrane region and 
cytoplasmic tail. In addition, all of the cysteine residues and a majority 
of the putative N-linked glycosylation sites in the extracellular domain 
were conserved between bovine, human and mouse. An area of low amino acid 
similarity between species was present within the extracellular domain. 
This area had a similarity of 34% between bovine and human, and 27% between 
bovine and mouse. The location of this area of low similarity was conserved 
between species. 
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INTRODUCTION 
Antibodies recognizing the Pgp-1, (In[Lu]) related-p80, ECMRIII, and 
Hermes lymphocyte homing antigens have been shown to recognize the same 
molecule, designated CD44 at the Third International Workshop on Leukocyte 
Differentiation Antigens (Cobbold et al., 1987). Recently, the cDNAs 
encoding for human, baboon, and mouse CD44 have been sequenced (Stamenkovic 
et al., 1989; Goldstein et al., 1989; Idzerda et al., 1989; Nottenburg et 
kl., 1989; Zhou et al., 1989). The CD44 membrane protein has been found on 
a wide variety of cells including lymphocytes, monocytes, granulocytes, 
fibroblasts, epithelial cells (Carter and Wayner, 1988; Flanagan et al., 
1989), erythrocytes (Telen et al., 1983), and cells in the brain (Flanagan 
et al., 1989). CD44 has been reported to be Involved in T-cell activation 
(Huet et al., 1989; Shimuzu et al., 1989; Haynes et al., 1988), to associate 
with cytoskeletal components and collagen (Carter and Wayner, 1988; 
Kalamoris and Bourguignon, 1988), recognize hyaluronate (Aruffo et al., 
1990), and to regulate lymphocyte homing to secondary lymphoid organs in man 
(reviewed by Stoolman, 1989; Butcher, 1990). 
Circulating lymphocytes exit the bloodstream and enter secondary 
lymphoid organs by attachment to and migration through post-capillary 
venules located in the paracortex (Gowans and Knight, 1964). The Hermes 
class of antibodies to CD44 may block homing by inhibiting the attachment 
of lymphocytes to the endothelium of these post-capillary venules in the 
lymph node paracortex (reviewed by Stoolman, 1989; Butcher, 1990). In 
humans and rodents these paracortical venules are lined with high-walled 
endothelium (Gowans and Knight, 1964; Jalkanen and Butcher, 1985; Smith and 
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Ford, 1983). While paracortical venules in ruminants do not have high-
walled endothelium, it has been demonstrated that circulating lymphocytes 
attach to and migrate through paracortical venules lined with low-walled 
endothelium (Harp et al., 1990). Therefore, it is reasonable to assume that 
the molecular mechanisms regulating adhesion between circulating lymphocytes 
and endothelial cells are similar in ruminant and non-ruminant species. 
In this paper, we report on the isolation and sequencing of a cDNA clone 
which encodes for bovine CD44. The predicted amino acid sequence of bovine 
CD44 demonstrated an overall high similarity with that of human and mouse 
CD44, 79.5% and 73.2%, respectively. While the overall similarity was high, 
an area of low similarity between bovine and other species (34% - 27%) was 
identified within the extracellular domain. Mouse and human also have a 
region of low similarity (35%) in the extracellular domain (Nottenburg et 
al., 1989). The location of this area of low similarity was conserved 
between species. 
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MATERIALS AND METHODS 
Isolation of bovine CD44 cDNA 
Approximately 30,000 recombinant clones from a bovine lymphocyte cDNA 
lambda gtll library (ATCC, Rockville, MD) were screened by hybridization 
with a ^ ^P-random primer labeled (Pharmacia LKB, Piscataway, NJ) baboon CD44 
cDNA clone (Idzerda et al., 1989) as previously described (Sambrook et al., 
1989). One clone that hybridized to the baboon CD44 cDNA was identified and 
the 1.4 kb insert cloned into the EcoR I site of the cloning vector plasmid 
pBluescript (Stratagene, La Jolla, CA). 
Sequencing strategy 
The DNA sequence of both strands of the bovine CD44 cDNA clone was 
determined as follows. The clone containing the 1.4 kb insert and subclones 
derived by digesting the 1.4 kb insert with restriction enzymes and 
subcloning into plasmid pBluescript (Stratagene) or pGem-5zf (Promega 
Biotec, Madison, WI) were used to generate single stranded filamentous 
bacteriophage using the helper bacteriophage M13K07 (Promega). 
Single-stranded phage and single-stranded DNA were recovered (Sambrook et 
al., 1989) and the sequence of the DNA was determined by the dideoxy chain 
termination method (Sanger et al., 1977) using T7 DNA polymerase 
(Pharmacia), primers specific for the cloning vectors and synthesized 
oligonucleotide primers specific for bovine CD44. 
Northern blot analysis 
Various bovine tissues were obtained at a local slaughter plant. Total 
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RNA was recovered by single extraction with an acid guanidinium thiocyanate-
phenol-chloroform mixture (Chomczynski and Sacchi, 1987) and poly(A)'*TlNA 
isolated using oligo dT chromatography (Aviv and Leder, 1972). Poly(A)'*TlNA 
from these tissues was subjected to electrophoresis in a denaturing agarose 
gel and transferred to a nylon membrane (Nytran, Schleicher & Schuell, 
Keene, NH). Prehybridization was carried out in 50% formamide, 5X 
Denhardt's, 5X SSPE, 0.5% SDS, and 0.1 mg/ml salmon sperm DNA for 4 hours 
at 42°C. Hybridization was carried out in the same buffer containing ^^P-
random primer labeled bovine CD44 cDNA overnight at 42°C. The nylon 
membrane was washed twice in 6X SSPE/0.5% SDS at room temperature, twice in 
IX SSPE/0.5% SDS at 37°C, and then exposed to X-ray film at -70°C. 
Computer analysis 
Sequence data were analyzed and amino acids deduced using the DNA 
sequence analysis programs written by Schwindinger and Warner (1984). 
Hydrophobicity of the deduced amino acid sequence was determined with the 
Hibio Prosis program (Pharmacia) using the method of Kyte and Doolittle 
(1982). Comparison of amino acid sequences was performed using the Align 
program (Scientific & Educational Software, Silver Spring, MD). 
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RESULTS AND DISCUSSION 
Characterization of the bovine cDNA encoding for CD44 
The DNA sequence of the bovine CD44 cDNA clone is presented in Figure 
1. The 1355 nucleotide cDNA contained one long open reading frame of 1089 
bases starting at base number 101. This start location agreed well with the 
consensus translation initiation sequence described previously (Kozak, 
1984). The 3' end of the cDNA terminated in a short poly(A) tail preceded 
by a possible polyadenylylation sequence, CATAAA, 14 bases upstream 
(Birnstiel et al., 1985). 
RNA expression analysis 
The 1.4 kb bovine CD44 cDNA was hybridized in Northern blot analyses 
to 1.5 ug of poly(A)"h(NA from three different bovine tissues (Figure 2). 
Three RNA bands of approximately 4.5, 2.3, and 1.7 kb were detected in RNA 
derived from mesenteric lymph node and liver. The two smaller bands were 
of similar intensity and were more intense than the faint 4.5 kb band. 
Similar sized CD44 mRNAs were detected in spleen, spinal cord, mammary lymph 
node, and lung (data not shown). The number and size of bovine CD44 mRNAs 
were similar to those found in human hematopoietic cells (Stamenkovic et 
al., 1989; Goldstein et al., 1989). Murine CD44 mRNAs have only two sizes 
and do not purify with polyadenylylated RNAs (Nottenburg et al., 1989). No 
CD44 mRNA was detected in poly(A)'^1RNA derived from bovine heart (Figure 2). 
Predicted amino acid sequence of bovine CD44 
The first 20 amino acids of the open reading frame (Figure 1) resembled 
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a possible leader peptide (von Heijne, 1986). Cleavage of the leader 
peptide would result in a mature protein with an apparent predicted 
molecular mass of 37.7 kD. The 253 amino acid long extracellular protein 
domain (amino acids 21-273) was rich in serine (12.6%) and threonine (9.8%) 
residues and contained seven potential N-linked glycosylation sites. The 
putative hydrophobic transmembrane region (amino acids 274-294) consisting 
of 21 neutral amino acids was followed by a 72 amino acid cytoplasmic domain 
(amino acids 295-366). The putative transmembrane region contained a single 
cysteine which may be a potential fatty acylation site (Kaufman, 1984). 
Comparison of the predicted amino acid sequence of bovine, human and mouse 
CD44 
A comparison of the predicted amino acid sequence of bovine, human and 
mouse CD44 is shown in Figure 3. Bovine CD44 had 79.5% and 73.2% amino acid 
sequence similarity with that of human and mouse CD44, respectively. The 
areas of highest similarity extended from bovine amino acids 1-187 and 
261-366. All three contained a putative leader peptide; the mouse leader 
peptide was 4 amino acids longer than that of bovine and human. Of the 
seven potential N-linked glycosylation sites in the bovine extracellular 
domain, six were present in human and five in mouse. The N-linked 
glycosylation sites that were present in bovine CD44, but not in mouse or 
human CD44, were within the area of low inter-species similarity. All 
cysteine residues in the extracellular and transmembrane regions, the amino 
acid sequence and location of the transmembrane region, and the length of 
the cytoplasmic tail were conserved between species. 
An area of low similarity between bovine, human and mouse was present 
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in the extracellular domain and extended from bovine amino acids 188-260. 
This region of low amino acid similarity had 34% and 27% identity with that 
of human and mouse, respectively. This same area is also the region of 
lowest similarity (35%) between human and mouse (Nottenburg et al., 1989). 
Minor differences included three-base insertions in bovine and murine CD44 
cDNA that did not alter the reading frame. 
The region of low similarity does not appear to be due to use of 
different exons in various species. In the mouse, one exon has been found 
to encompass amino acids 152-227. The area of low inter-species similarity 
starts within this exon at mouse amino acid 187 and extends well beyond it 
to amino acid 259 (Nottenburg et al., 1989). This region of low inter­
species similarity is contained in the region possibly involved in the 
binding of human lymphocytes to high-walled endothelial venules (Goldstein 
et al., 1989). If some of the adhesive functions of CD44 involve specific 
polypeptides in the region of low similarity (amino acids 188-259), this 
region may mediate certain species-specific types of cellular adhesion. 
Another possibility is that the area of lowest amino acid similarity has a 
limited role in adhesion, allowing variation between species without 
affecting certain adhesive functions of CD44. 
In conclusion, we have isolated and sequenced a bovine CD44 cDNA clone 
and subsequently deduced the amino acid sequence. The overall similarity 
between the predicted amino acid sequence of bovine, human and mouse CD44 
was extensive. Conservation of N-linked glycosylation and cysteine residues 
suggests that the proteins may assume similar three dimensional structures. 
There was a region of low amino acid similarity between species which may 
alter protein folding; however, the location of this region was conserved 
between species. 
GGGGTTCGGGCGCCCTGCTTGCCCCGTGCTCCGCCGGCCCCCGCCCAGCGCCCGGCCCCTCCGGCTCCAC 70 
TCCGCTCGCTCGGTCGGTCGCTCCACGCC ATG GAC ACG TTT TGG TGG 117 
Met ASP Thr Phe Trp Trp 6 
CGC GCA GCC TGG GGA CTC TGC CTC GTG CAG CTG AGC CTG GCG CAG ATC GAT CTG 172 
Are Ala Ala Trp Glv Leu Cvs Leu Val Gin Leu Ser Leu Ala Gin lie Asp Leu 24 
AAT ATA ACC TGC CGA TAT GCA GGT GTA TTC CAC GTG GAG AAG AAT GGT CGC TAT 226 
Asn lie Thr Cys Arg Tyr Ala Gly Val Phe His Val Glu Lys Asn Gly Arg Tyr 42 
AGC ATC TCT AAG ACT GAG GCT GCT GAC CTC TGC AAG GCC TTT AAT AGC ACG CTG 280 
Ser lie Ser Lys Thr Glu Ala Ala Asp Leu Cys Lys Ala Phe Asn Ser Thr Leu 60 
CCC ACC ATG GCC CAG ATG GAG GCG GCC CGG AAC ATA GGG TTT GAG ACC TGC AGG 334 
Pro Thr Met Ala Gin Met Glu Ala Ala Arg Asn lie Gly Phe Glu Thr Cys Arg 78 
TAC GGG TTC ATA GAA GGG CAT GTG GTG ATT CCC CGG ATC CAC CCC AAT TCC ATC 388 
Tyr Gly Phe lie Glu Gly His Val Val Ile Pro Arg Ile His Pro Asn Ser lie 96 
TGT GCT GCG AAC AAC ACG GGG GTG TAG ATC CTC ACA TCC AAC ACC TCC CAG TAT 442 
Cys Ala Ala Asn Asn Thr Gly Val Tyr lie Leu Thr Ser Asn Thr Ser Gin Tyr 114 
GAC ACG ATC TGC TTC AAT GCC TCA GCT CCA CCT GGG GAA GAC TGT ACA TCG GTC 496 
Asp Thr lie Cys Phe Asn Ala Ser Ala Pro Pro Gly Glu Asp Cys Thr Ser Val 132 
ACG GAC CTG CCC AAT GCC TTT GAA GGA CCA ATT ACC ATA ACT ATT GTA AAC CGT 550 
Thr Asp Leu Pro Asn Ala Phe Glu Gly Pro lie Thr lie Thr lie Val Asn Arg 150 
GAT GGC ACC CGT TAT ACC AAG AAA GGC GAA TAC AGA ACT AAC CCA GAA GAC ATC 604 
Asp Gly Thr Arg Tyr Thr Lys Lys Gly Glu Tyr Arg Thr Asn Pro Glu Asp lie 168 
AAC CCC AGC GTC GTT AGC CCC AGC AGC CCT CCT GAC GAT GAG ATG AGC AGC GGC 658 
Asn Pro Ser Val Val Ser Pro Ser Ser Pro Pro Asp Asp Glu Met Ser Ser Gly 186 
TCC CCC AGT GAG AGA AGC ACT TCA GGA GGC TAC AGC ATC TTC CAC ACG CAC CTC 712 
Ser Pro Ser Glu Àrg Ser Thr Ser Gly Gly Tyr Ser lie Phe His Thr His Leu 204 
CCA ACT GTG CAC CCG TCC AGA CCA AGA CGG CCC TGG TCT CAG CGA GCA GAG AAT 766 
Pro Thr Val His Pro Ser Arg Pro Arg Arg Pro Trp Ser Gin Arg Ala Glu Asn 222 
ACC TCG GAT ACC AGA GAC TAC GGC TCG TCC CAC GAC CCC AGT GGA AGA TCC TAT 820 
Thr Ser Asp Thr Arg Asp Tyr Gly Ser Ser His Asp Pro Ser Gly Arg Ser Tyr 240 
ACA ACT CAC GCA TCT GAA TCA GCT GGA CAC TCA AGT GGG AGT GAA GAA CAT GGG 874 
Thr Thr His Ala Ser Glu Ser Ala Gly His Ser Ser Gly Ser Glu Glu His Gly 258 
Figure 1. cDNA sequence of bovine CD44. Potential N-linked glycosylation 
sites are double underlined; putative leader peptide and trans­
membrane region are underlined 
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GCA AAC AGA ACG TCA GGT GCT ATG GGG AAA GCT GAA ATT CCA GAA TGG CTG ATG 928 
Ala Asn Thr Thr Ser Gly Pro Met Arg Lys Pro Gin lie Pro Glu Tro Leu lie 276 
ATG TTG GGA TGT CTG CTG GCC TTG GCT TTG ATT GTG GCG GTT TGG ATT GCT GTG 982 
lie Leu Ala Ser Leu Leu Ala Leu Ala Leu lie Leu Ala Val Cvs lie Ala Val 294 
#c 
Asn 
AGT 
Ser 
AGG 
Arg 
AGA 
Arg 
AGG 
Arg 
TGT 
Cys 
GGG 
Gly 
CAG 
Gin 
AAG 
Lys 
AAA 
Lys 
AAA 
Lys 
CTG 
Leu 
GTG 
Val 
ATG 
lie 
AAC AAT 
Asn Asn 
GGG 
Gly 
AAT 
Asn 
1036 
312 
GGA 
Gly 
ACG 
Thr 
ATG 
Met 
GAG 
Glu 
GAG 
Glu 
AGA 
Arg 
AAG 
Lys 
GCG 
Pro 
AGG 
Ser 
GGA 
Gly 
CTG 
Leu 
AAC 
Asn 
GGA 
Gly 
GAA 
Glu 
GCT AGG 
Ala Ser 
AAG 
Lys 
TGT 
Ser 
1090 
330 
CAG 
Gin 
GAG 
Glu 
ATG 
Met 
GTG 
Val 
CAT 
His 
TTG 
Leu 
GTG 
Val 
AAC 
Asn 
AAG 
Lys 
GGG 
Gly 
TGG 
Ser 
TCA 
Ser 
GAG 
Glu 
ACG 
Thr 
CCA GAG 
Pro Asp 
GAG 
Gin 
TTC 
Phe 
1144 
348 
ATG 
Met 
ACG 
Thr 
GCA 
Ala 
GAT 
Asp 
GAG 
Glu 
ACG 
Thr 
CGG 
Arg 
AAC 
Asn 
TTG 
Leu 
CAG 
Gin 
AAT 
Asn 
GTG 
Val 
GAT 
Asp 
ATG 
Met 
AAG ATT 
Lys Ile 
GGG 
Gly 
GTG 
Val 
1198 
366 
TAACAGCTAGTTCATGACCTTGGAAATAAACCAGCATTGGAGACACAACTATTACAGGGAGCTGGGACAC 1268 
TTCACAGATGCAATGTGCTACTGATTGTTTCATTGGGGATCTTrTTTTrTTAGCATAAAATTTTCTATTC 1338 
CTTTAAAAAAAAAAAAA 1355 
32 
A B C  
7 .5 -
4 .4 -
2 .4 -
1 .4 -
Figure 2. RNA analysis of the CD44 gene. 1.5 ug of poly(A)'*%fA from bovine 
heart (A), liver (B), and mesenteric lymph node (C) was 
electrophoresed, transferred to a nylon membrane, and hybridized 
with labeled bovine CD44 cDNA. The numbers on the left 
correspond to the sizes of a RNA ladder 
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25 50 
MDTFWWRAAWGLCLVQLSLA QIDLNITCRYAGVFHVEKNGRYSISKTEAADLCKAF 
P F R 
. .K. . .HT L HPHQ V R Q. . 
BOVINE 
HUMAN 
MOUSE 
75 100 
NSTLPTMAQMEAARNIGFETCRYGFIEGHWIPRIHPNSICAANNTGVYIL-TSNTSQYD 
K.LS -.Y 
D. .KL.LSK N A H V H. . 
BOVINE 
HUMAN 
MOUSE 
125 150 175 
TICFNASAPPGEDCTSVTDLPNAFEGPITITIVNRDGTRYTKKGEYRTNPEDINPSWSP BOVINE 
.Y E D VQ Y. HUMAN 
.Y E S.D..V S HQ... DA MOUSE 
200 225 
S S PPDDEMS SGSPS ERSTSGGYSIFHTHLPTVHPSRPRRPWSQRAENTSDTRDYGSSHDP 
.N.T..DV S STS.GY..Y. FSTVHPIPDEDS. . ITDSTDRIPATRDQDTFH. 
.Nil..DV TI.K..PES.-.L..Y...EQ.TGDQDDSFFIRSTLATRDRDS.KDSR 
250 275 
SGRSYTTHASESAGHSSGSEEHGANTTSGPMRKPQIPEWLIILASLLALALILAVCIAVN 
. .G.H. . .E...D...H. .Q.G I.T 
GSSRTV. .G. .L ANQDS.VT R 
BOVINE 
HUMAN 
MOUSE 
BOVINE 
HUMAN 
MOUSE 
300 325 350 
SRRRCGQKKKLVINNGNGTMEERKPSGLNGEASKSQEMVHLVNKGSSETPDQFMTADETR BOVINE 
S...AV.D E HUMAN 
G V.D....E EP C MOUSE 
NLQNVDMKIGV BOVINE 
HUMAN 
... S MOUSE 
Figure 3. Comparison of the amino acid sequences of CD44. The amino acid 
sequence (one letter designation) determined from the bovine CD44 
cDNA is shown on the top line. Amino acid differences in human 
(Stamenkovic et al., 1989) and the C3H strain of mouse (Notten-
burg et al., 1989) are shown. Amino acid similarity is 
designated with a dot (.) and deletions with a dash (-) 
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ABSTRACT 
In rodents and humans, lymphocytes circulate throughout the body and 
return preferentially to their tissues of origin via a process termed 
homing. The specificity of homing is controlled by the binding of tissue-
specific receptors on lymphocytes to ligands on specialized high-walled 
endothelial venules (HEV) found in lymphoid tissue. The murine and human 
peripheral lymphocyte homing receptors (PLHR) have been characterized and 
shown to be similar to each other. We present evidence for a similar 
receptor in the bovine. Bovine peripheral blood lymphocytes (PBL) bound to 
the HEV of murine peripheral lymph node tissue in vitro. The same 
carbohydrates that have been shown to decrease the binding of murine or 
human lymphocytes to murine HEV also decreased the binding of bovine PBL to 
murine HEV. Neuraminidase treatment affected lymphocyte binding in a 
similar manner in the bovine, murine, and human species. Phorbol myristate 
acetate (PMA) stimulation, which has been shown to reduce the expression of 
murine and human PLHR, also reduced the binding of bovine PBL to murine HEV. 
These data suggest conservation of PLHR between these species. 
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INTRODUCTION 
Lymphocyte homing is the process by which lymphocytes recirculate 
throughout the body and return to lymphoid tissues (Gowans and Knight, 1964; 
Butcher, 1990; Stoolman, 1989). In rodents and humans, the specificity of 
homing is controlled by adhesive interactions of homing receptors on 
lymphocytes with vascular addressins on high-walled endothelial venules 
(HEV) (Gallatin et al., 1983; Kishimoto et al., 1990; Streeter et al., 
1988a, 1988b). Murine and human lymphocyte homing receptors and vascular 
addressins have been studied and characterized using an in vitro HEV binding 
assay. This HEV assay detects tissue-specific adhesive interactions of 
lymphocytes to HEV in frozen sections of either peripheral lymph nodes or 
Beyer's patches and predicts migratory activity in vivo (for review, see 
Butcher, 1990; Stoolman, 1989). 
The murine and human peripheral lymphocyte homing receptors (PLHR) have 
been characterized and shown to be very similar to each other (Gallatin et 
al., 1983; Bowen et al., 1989; Kishimoto et al., 1990; Lasky et al., 1989; 
Siegelman et al., 1989; Siegelman and Weissman, 1989). Sequence analysis 
of the cDNA encoding for murine and human PLHR reveals an extracellular 
lectin-like domain (Bowen et al., 1989; Lasky et al., 1989; Siegelman et 
al., 1989; Siegelman and Weissman, 1989). Evidence that this lectin domain 
is involved in homing of peripheral lymphocytes includes the ability of 
carbohydrates, such as mannose-6-phosphate (M6P), fructose-1-phosphate 
(FIP), and fucoidin, to inhibit the binding of lymphocytes to peripheral 
lymph node HEV (Stoolman and Rosen, 1983; Stoolman et al., 1984; Stoolman 
et al. , 1987). The aforementioned carbohydrates compete with each other for 
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binding to purified PLHR (Imai et al., 1990). Also, the antibody MEL-14, 
which blocks homing of murine peripheral lymphocytes, binds to the lectin 
domain of PLHR (Bowen et al., 1990). 
In this report, we present evidence for a receptor in the bovine that 
is similar to murine and human PLHR. Bovine peripheral blood lymphocytes 
(PBL) bound preferentially to HEV of murine peripheral lymph node tissue in 
vitro. Carbohydrates that have been shown to decrease binding of murine or 
human lymphocytes to murine HEV also decreased the binding of bovine PBL to 
murine HEV. Neuraminidase treatment affected lymphocyte binding in a 
similar manner in the bovine, murine, and human species. Phorbol myristate 
acetate (PMA) stimulation, which has been shown to reduce the expression of 
murine and human PLHR (Huang et al., 1989; Jung and Dailey, 1990; Kishimoto 
et al., 1990), reduced the binding of bovine PBL to murine HEV. These data 
suggest that structure and function of PLHR are conserved between these 
species. 
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MATERIALS AND METHODS 
Cell preparation 
Bovine PBL were collected by centrifugation at 450 g for 40 min over 
Percoll (sp gr - 1.084) as previously described (Whitmire and Harp, 1991). 
Platelets were removed from the PBL by centrifugation through Percoll (sp 
gr = 1.029). The PBL were then washed in assay buffer (RPMI 1640; Gibco 
Laboratories, Grand Island, NY; supplemented with 5% fetal bovine serum). 
Bovine PBL in assay buffer were then labeled with Hoechst 33342, a 
fluorescent dye that binds DNA (Sigma Chemical Co, St. Louis, MO; 0.6 ug/ml, 
30 min at 39°C). Murine splenocytes and Peyer's patch lymphocytes from 
adult BALB/c mice were labeled with fluorescein isothiocyanate (FITC; Sigma; 
50 ug/ml, 30 min at 37°C). After labeling, lymphocytes were pelleted by 
centrifugation through fetal bovine serum, to remove unbound label and dead 
cells, and then washed in assay buffer. 
HEV assay 
Axillary, mesenteric and popliteal lymph nodes, and Peyer's patches 
were removed from adult BALB/c mice for use in the HEV binding assay 
described previously (Butcher et al, 1979; Stamper and Woodruff, 1976; 
Stoolman et al., 1987). Briefly, lymphoid tissue imbedded in O.C.T. (Miles 
Inc, Elkhart, IN) was frozen on dry ice and sectioned with a cryostat. 
Tissue sections were placed on glass slides. The O.C.T. was removed with 
forceps and sections were overlaid with 100 ul of lymphocyte suspension in 
assay buffer. Sections were rotated at 60 RPM on a horizontal rotary shaker 
for 30 min at 5°C. The sections were then fixed in 3% glutaraldehyde in 
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phosphate-buffered saline (PBS) for 45 min, rinsed in PBS, and examined 
microscopically with darkfield/fluorescent illumination. 
Tissue specificity of bovine PBL binding 
Hoechst-labeled bovine PBL (2 X 10^/ml) were mixed at a 10 to 1 ratio 
with FITC-labeled murine splenocytes or Peyer's patch lymphocytes (2 X 
lO^/ml). Samples containing bovine PBL and murine splenocytes were used to 
overlay sections of murine peripheral lymph nodes (axillary and popliteal). 
Samples containing bovine PBL and murine Peyer's patch lymphocytes were used 
to overlay sections of murine Peyer's patches. The numbers of bovine and 
murine lymphocytes bound to HEV were determined by visually identifying and 
then counting lymphocytes bound to HEV. The specific adherence ratio (SAR) 
was calculated as previously described by dividing the ratio of bovine to 
murine lymphocytes bound to HEV by the ratio of bovine to murine lymphocytes 
used to overlay the lymph node sections (Butcher et al., 1979). 
Neuraminidase. PMA, and carbohydrate treatment 
Bovine PBL in assay buffer (IX 10^/ml) were incubated for 30 min at 
39°C with 0.5 U/ml neuraminidase, 1 ug/ml phorbol PMA, or medium alone. The 
bovine PBL were then washed in assay buffer and resuspended along with FITC-
labeled murine splenocytes at a 10 to 1 ratio (2 X 10^/ml bovine, 2 X 10^/ml 
murine). The bovine and murine lymphocytes were overlaid on murine mesen­
teric lymph node sections, and the SAR was determined as described above. 
Murine lymph node sections were pre-incubated for 30 min at 37°C with 
either PBS alone or PBS containing 0.5 U/ml of neuraminidase as described 
(Rosen et al., 1985), washed in PBS, and then overlaid with bovine PBL (2 
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X 10^/ml) in assay buffer. Murine lymphocytes were not used as an internal 
control in these experiments, since the treatment of lymph node sections 
would have affected the binding of both murine and bovine lymphocytes. 
In experiments testing the effects of carbohydrates, bovine PBL in 
assay buffer (2 X 10^/ml) were incubated for 15 min on ice with 5 mM 
fructose-l-phosphate (FIP), 5 mM fructose-6-phosphate (F6P), 1 ug/ml 
fucoidin, or medium alone before being overlaid on mesenteric lymph node 
sections. The aforementioned carbohydrates were included with the bovine 
PBL during the incubation on murine lymph node sections, Murine lymphocytes 
were not added as an internal control since the carbohydrates would also 
have interfered with their binding to HEV. The neuraminidase, PMA, and 
carbohydrates used in these experiments were obtained from Sigma. 
Experimental Design and Data Analysis 
Experiments were performed on separate days for each treatment regimen 
or tissue-specific HEV assay. Each experiment consisted of an average of 
eight replicate sections. The binding of bovine PBL relative to the 
internal control (murine lymphocytes) was determined by calculating the SAR 
as described above. 
When murine lymphocytes could not be used as an internal control, 
consecutively cut tissue sections containing HEV of similar size and number 
were used to assess lymphocyte binding. The total number of lymphocytes 
bound to HEV in all treated or control samples for each experiment was 
counted and compared to determine the percent binding in treated, relative 
to control, samples. 
The standard error of the mean (SEM) represents the variation between 
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separate experiments done on different days. Treatments that the 
lymphocytes or lymph node sections had received were not known to the person 
determining the number of lymphocytes bound to HEV. Over 90% of the treated 
lymphocytes were viable, based on their ability to exclude trypan blue dye. 
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RESULTS 
Bovine PBL bound preferentially to murine peripheral node HEV compared 
with murine Peyer's patch HEV. The average SAR for binding to peripheral 
nodes and Peyer's patches was 0.83 and 0.13, respectively (Table 1). Bovine 
PBL bound primarily to HEV of lymph nodes with a limited amount of binding 
to medullary sinuses (Figure la). 
Hoechst 33342 did not affect binding of murine or bovine lymphocytes 
to HEV. In one experiment, the labels were reversed; i.e., bovine PBL were 
FITC-labeled and murine splenocytes were Hoechst-labeled (Figure lb and 
Table 1, Experiment 3). There were no differences in the SAR from this 
experiment compared with the SAR in experiments with Hoechst-labeled bovine 
PBL and FITC-labeled murine splenocytes (Figure la and Table 1, Experiments 
1 and 2). Hoechst 33342 appeared to be a better label than FITC, as the 
intensity was greater, the cells retained fluorescence for an extended 
period of time, and a 100-fold increase in the concentration of Hoechst 
33342 did not affect bovine PBL binding in the HEV assay (data not shown). 
The presence of FIP and fucoidin in the HEV assay reduced the binding 
of bovine PBL to murine HEV to about one-third of control levels (Table 2). 
Conversely, F6P did not affect the binding of bovine PBL as compared with 
controls (Table 2). Treatment of bovine PBL with 0.5 U/ml neuraminidase 
caused a 150% increase in HEV binding relative to controls. 
Stimulation of bovine PBL with PMA decreased their binding to HEV 
(Table 3). The.SAR of bovine PBL treated with PMA was reduced to 26% and 
24% of the control SAR in experiments 1 and 2, respectively. 
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Figure la. Binding of bovine and murine lymphocytes to murine HEV. Hoechst-
labeled bovine PBL (arrows) and FITC-labeled murine splenocytes 
(arrowheads) are binding to murine HEV, The murine HEV is darker 
than the surrounding lymphoid tissue 
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Figure lb. Binding of bovine and murine lymphocytes to murine HEV. FITC-
labeled bovine PBL (arrows) and Hoechst-labeled murine 
splenocytes (arrowheads) are binding to murine HEV. Reversal of 
Hoechst and FITC labels had no effect on the specificity of 
lymphocyte binding in the HEV assay 
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TABLE 1. Binding of bovine PBL to murine HEV 
Exp. # Peripheral Lymph Node HEV& Peyer's Patch HEV^ 
1 121/16= (0.76)d 91/82 (0.11) 
2 559/61 (0.92) 123/80 (0.15) 
3 474/59 (0.80) ND® 
Average 0.83 + O.OSf 0.13 + 0.02 
^Bovine PBL and murine splenocytes (10 to 1 ratio) were used to overlay 
murine peripheral lymph node sections. 
^Bovine PBL and murine Peyer's patch lymphocytes (10 to 1 ratio) were 
used to overlay murine Peyer's patch sections. 
•^Numbers of bovine PBL/murine lymphocytes bound to HEV. 
^SAR (in parentheses), determined as previously described (Butcher et 
al., 1979). 
®ND, not done. 
^Average SAR + SEM. 
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TABLE 2. Effects of carbohydrates on bovine PBL binding to murine HEV& 
Treatment 
Exp. # FlP F6P Fucoidin 
1 89/248% (36%)° 320/317 (101%) 267/732 (36%) 
2 196/535 (37%) 522/535 (98%) 108/404 (32%) 
Average 36.5% + 1%^ 99% + 2% 34% + 2% 
^Bovine PBL were incubated with 5 mM fructose-l-phosphate (FlP), 5 mM 
fructose-6-phosphate (F6P), 1 ug/ml fucoidin, or medium alone, and then 
overlaid on murine mesenteric lymph node sections. 
^Numbers of treated bovine PBL/control bovine PBL bound to HEV. 
°The percent binding of treated PBL, relative to PBL treated with 
medium alone (in parentheses). 
•^Average percent binding of treated PBL, relative to PBL treated with 
medium alone, + SEM. 
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TABLE 3. Effect of PMA treatment on bovine PBL binding to murine HEV& 
Exp. # Control PMA 
1 437/103% (0.42)C 86/79 (0.11) 
2 400/81 (0.49) 84/67 (0.12) 
Average 0.44 + 0.04^ 0.12 + 0.01 
^Bovine PBL were incubated with PMA or medium alone (control), mixed 
10 to 1 with murine splenocytes, and overlaid on murine mesenteric lymph 
node sections. 
^Numbers of bovine PBL/murine splenocytes bound to HEV. 
•^SAR (in parentheses), determined as previously described (Butcher et 
al., 1979). 
^Average SAR + SEM. 
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DISCUSSION 
Murine and human PLHR are similar; both contain a lectin domain and the 
binding of lymphocytes to HEV in both species is inhibited by specific 
carbohydrates (Bowen et al., 1989; Lasky et al., 1989; Siegelman et al., 
1989; Siegelman and Weissman, 1989; Stoolman et al., 1987). In the present 
study, FIP and fucoidin inhibited bovine PBL binding to murine HEV. These 
same carbohydrates inhibit binding of murine peripheral lymphocytes to 
murine HEV (Stoolman et al., 1987). The carbohydrate F6P, which does not 
affect binding of murine lymphocytes to HEV (Stoolman et al., 1987), had no 
effect on bovine PBL binding in the present study. The similar effects of 
carbohydrates on lymphocyte binding suggest conservation of a lectin domain 
in PLHR of all three species. 
Removal of sialic acid residues from bovine lymphocytes with 
neuraminidase increased binding to murine HEV. Previous studies examining 
the binding of human PBL to murine HEV also reported an increase in binding 
after neuraminidase treatment (Stoolman et al., 1987). This increased 
binding after sialic acid removal may be due to the decrease in negative 
charge on the lymphocyte which could enhance binding to HEV (Stoolman et 
al., 1987). Conversely, neuraminidase treatment of murine lymph node 
sections has been reported to decrease binding of murine lymphocytes to 
peripheral HEV (Rosen et al., 1985), We saw a similar reduction in binding 
of bovine PBL following neuraminidase treatment of lymph node sections (data 
not presented). It has been suggested that sialic acid residues on murine 
peripheral HEV interact with PLHR, and that neuraminidase treatment 
decreases lymphocyte binding by removing the sialic acid residues from the 
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HEV vascular addressins (Rosen et al., 1985; True et al., 1990). The 
reduction in the binding of both bovine PBL and murine lymphocytes to murine 
HEV after neuraminidase treatment of the HEV suggests that PLHR of both 
species recognize the same vascular addressins. 
Murine and human PLHR are rapidly down-regulated by a variety of 
stimulatory agents, including PMA (Huang et al., 1989; Jung and Dailey, 
1990; Kishimoto et al., 1990). In the present study, binding of bovine PBL 
to murine HEV was decreased by pretreatment of the PBL with PMA. This 
suggests that the bovine receptor may possibly be down-regulated by PMA. 
In summary, the ability of bovine PBL to bind to murine HEV and the 
similarities between the effects of carbohydrates, neuraminidase, and PMA 
on binding of bovine, murine, and human lymphocytes in the HEV assay suggest 
that PLHR are conserved in all three species. Definitive identification of 
the bovine receptor will be facilitated by isolation and sequencing of a 
cDNA encoding the bovine equivalent of the murine and human PLHR. 
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ABSTRACT 
The bovine cDNA clones encoding for bovine LECAM-1 (lectin cell 
adhesion molecule-1) were isolated and sequenced. The predicted amino acid 
sequence of bovine LECAM-1 showed high identity with that of human and 
murine LECAM-1. The antibody DREG-56, which recognizes human LECAM-1, 
blocked the binding of bovine peripheral blood lymphocytes to high-walled 
endothelial venules in murine peripheral lymph nodes. Surface expression 
of bovine LECAM-1 was high in lymphocytes isolated from peripheral lymph 
nodes and low in lymphocytes isolated from Peyer's patches. This evidence 
strongly suggests that bovine LECAM-1 is a peripheral lymphocyte homing 
receptor. 
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INTRODUCTION 
Lymphocyte homing is the process by which lymphocytes recirculate 
throughout the body and return to lymphoid tissues (Cowans and Knight, 1964; 
Gallatin et al., 1986). In rodents and humans, the specificity of homing 
is controlled by adhesive interactions of homing receptors on lymphocytes 
with vascular addressins on high-walled endothelial venules (HEV) (Gallatin 
et al., 1983; Kishimoto et al., 1990; Streeter et al., 1988a, 1988b). 
Lymphocytes home to secondary lymphoid organs such as peripheral lymph 
nodes, or mucosal lymphoid tissues like the Peyer's patch (for review, see 
Stoolman, 1989; Butcher, 1990). 
The murine and human peripheral lymphocyte homing receptors, recently 
termed LECAM-1 (lectin cell adhesion molecule-1), have been characterized 
and the cDNAs encoding for them sequenced (Siegelman et al., 1989; Bowen et 
al., 1989; Lasky et al., 1989; Siegelman and Weissman, 1989). The predicted 
amino acid sequences of human and murine LECAM-1 have a domain that is 
homologous to a number of calcium-dependent animal lectins (Bowen et al., 
1989; Lasky et al., 1989; Siegelman et al., 1989; Siegelman and Weissman, 
1989). As specific carbohydrates block the binding of human and murine 
lymphocytes to peripheral lymph node HEV (Stoolman and Rosen, 1983, Stoolman 
et al., 1984; Stoolman et al., 1987), the lectin domain of human and murine 
LECAM-1 is likely involved in the binding of lymphocytes to peripheral lymph 
node HEV. Also, the monoclonal antibody MEL-14, which blocks the binding 
of murine lymphocytes to peripheral lymph node HEV in vitro and lymphocyte 
homing to peripheral lymph nodes in vivo, recognizes the lectin domain of 
LECAM-1 (Bowen et al., 1990). 
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Human and murine LECAM-1 also contain a domain with homology to 
proteins in the epidermal growth factor (EGF) family. This domain may have 
a role in lymphocyte homing. A monoclonal antibody that reacts with the 
EGF-like domain of murine LECAM-1 reduced the binding of murine lymphocytes 
to peripheral lymph node HEV in vitro (Siegelman et al., 1990). The exact 
role the EGF-like domain plays in HEV binding has been speculated to be due 
a direct role in HEV binding. However, it is possible that the antibody 
that reacted with the EGF-like domain reduced HEV binding due to secondary 
changes or steric influences induced on the lectin domain of LECAM-1 
(Siegelman et al., 1990). Murine and human LECAM-1 contain two repeated 
domains that show homology to a number of proteins, most of which have a 
role in complement-binding (Bowen et al., 1989; Lasky et al., 1989; 
Siegelman et al., 1989; Siegelman and Weissman, 1989). The role of the 
domains similar to complement-binding proteins in lymphocyte homing has not 
been established. 
Previously, we have shown that the bovine peripheral lymphocyte homing 
receptor is an evolutionarily conserved molecule with lectin activity. 
Carbohydrates that block the binding of murine and human lymphocytes to 
peripheral lymph node HEV also block the binding of bovine lymphocytes to 
peripheral lymph node HEV and both neuraminidase and phorbol myristate 
acetate have similar effects in all three species (Bosworth and Harp, 1991). 
In the present study, we have isolated and sequenced bovine LECAM-1 cDNA and 
blocked the binding of bovine lymphocytes to peripheral lymph node HEV with 
an antibody to human LECAM-1. Taken together, these data strongly suggest 
that bovine LECAM-1 is a peripheral lymphocyte homing receptor. 
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MATERIALS AND METHODS 
Cell preparation 
Lymphocytes from bovine mammary and prescapular lymph nodes and Peyer's 
patches were isolated as previously described (Harp et al., 1988). Briefly, 
bovine lymphoid tissues were removed from an adult female bovine and placed 
immediately on ice. The tissue was gently minced over a wire screen and 
cells that passed through were collected in medium (RPMI with 5% fetal 
bovine serum; Gibco Laboratories, Grand Island, NY). Bovine peripheral 
blood lymphocytes (PEL) were isolated by centrifugation at 450 g for 40 min 
over Percoll (sp gr - 1.084) as previously described (Whitmire and Harp, 
1991). Platelets were removed from the PBL by centrifugation at 250 g for 
10 minutes through Percoll (sp gr - 1.029). 
Antibodies and fluorescence-activated cell sorter (FAGS') analysis 
Bovine lymphocytes (1 x 10^) in 100 ul medium were incubated with 50 
ug/ml of DREG-56 (kindly provided by Dr. Mark Jutila, Montana State 
University, Bozeman, MT), an IgG^ monoclonal antibody that recognizes human 
LECAM-1 (Kishimoto et al., 1990; Jutila et al., 1990), or an isotype-matched 
control antibody. After a 15 min incubation at room temperature, 
lymphocytes were washed twice in phosphate-buffered saline (PBS). Next, 
lymphocytes were incubated with goat anti-mouse IgG-fluorescein 
isothiocyanate (FITC) conjugate (Sigma Chemical Co., St. Louis, MO) for 15 
rain at room temperature. After washing twice in PBS, cells were fixed with 
1% paraformaldehyde. Fluorescence analysis was performed on 10,000 cells 
at Iowa State University, Ames, lA using a EPICS 752 flow cytometer (Coulter 
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Electronics, Inc., Hialah, FL). Lymphocytes were identified by their 
characteristic pattern of forward and right angle light scatter. 
Fluorescence data are presented as the percentage staining above control 
antibody background and as histograms. 
HEV assay 
Murine popliteal lymph nodes or Peyer's patches were used in an HEV 
binding assay similar to that described previously (Butcher et al., 1979; 
Stamper and Woodruff, 1976; Stoolman et al. , 1987; Bosworth and Harp, 1991). 
Briefly, murine lymphoid tissue imbedded in O.C.T. (Miles Inc., Elkhart, IN) 
was frozen on dry ice and sectioned with a cryostat. Tissue sections were 
placed on glass slides. The O.C.T. was removed with forceps and sections 
were overlaid with 1 x 10^ bovine lymphocytes suspended in 100 ul medium. 
Sections were rotated at 60 RPM for 30 min at 5°C. The sections were then 
fixed in 3% glutaraldehyde in PBS for 45 min, rinsed in PBS, and examined 
microscopically with darkfield/fluorescent illumination. 
To determine the relative affinity of lymphocytes from prescapular and 
mammary lymph nodes for peripheral node HEV, FITC-labeled lymphocytes from 
prescapular lymph nodes and mammary lymph node lymphocytes labeled with 
Hoechst 33342, a fluorescent dye that binds DNA, were mixed at a 1:1 ratio 
in medium and then overlaid on peripheral lymph node sections (Bosworth and 
Harp, 1991). To determine the effect of DREG-56 on lymphocyte binding in 
the HEV assay, lymphocytes were incubated for 30 min on ice with 50 ug/ml 
of DREG-56 or an isotype-matched control antibody. These lymphocytes were 
then overlaid on either popliteal lymph node sections or Peyer's patch 
sections. 
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Isolation of bovine LECAM-1 cDNA 
A bovine LECAM-1 cDNA clone isolated from a bovine lymph node cDNA 
lambda gtlO library was kindly provided by Don Dowbenko, Genentech Inc. , San 
Francisco, CA. The 2.0 kb insert from this clone was subcloned into the 
cloning vector plasmid pBluescript (Stratagene, La Jolla, CA). 
Approximately 300,000 recombinant clones from a bovine lymphocyte cDNA 
phagemid library were screened with labeled cDNA that encodes for the 
lectin domain of bovine LECAM-1 (kindly provided by Bruce Walcheck, Montana 
State University, Bozeman, MT) as previously desribed (Sambrook et al. , 
1989). One positive clone was isolated which contained a 1.1 kb fragment. 
As cDNA sequencing showed that neither of these clones contained the 
entire 5' region of bovine LECAM-1, we produced cDNA encoding for the 5' 
region using the rapid amplification of cDNA ends (RACE) procedure (Frohman 
et al., 1988). Briefly, 1 ug of poly(A)+RNA was reverse transcribed using 
a primer complementary to LECAM-1 mRNA (5 '-CCACACATTGTCCATGGCCGCTG-3 ' ). The 
excess primer was removed with a Centricon 100 spin filter (W. R. Grace and 
Co., Danvers, MA) and then the cDNA was poly(A) tailed using terminal 
deoxynucleotidyl-transferase (Bethesda Research Laboratories, Gaithersburg, 
MD). Five ul of the tailed cDNA, 25 pmol each of adaptor primers (5'-
GACTCGAGTCGACAAGCTTTTTTTTTTTTTTTTT-3 ' and 5 ' -CGGAATTCTGTGTCAGGCATCATCATTCC-
3'), 1.5 mM deoxynucleotides, 10% dimethyl sulfoxide, 1 unit of the 
polymerase enhancer Perfect Match (Stratagene), and IX Tag polymerase buffer 
were denatured at 95°C for 5 min and then cooled to 72°C. Then 2.5 units 
of Tag DNA polymerase ( Perkin-Elmer - Cetus, Norwalk, CT) were added, and the 
temperature was reduced to 57°C for 1 min. The cDNA was extended for 40 min 
at 72°C and then the mixture was amplified in a DNA thermal cycler (Perkin-
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Elmer-Cetus) using a step program (35 cycles; 94°C, 40 sec; 59°C, 2 min; 
72°C, 3 min). The amplified cDNA was digested with Xho I and EcoR I and 
then subcloned into plasmid pBluescript. This RACE procedure was done on 
two separate occasions and 3 clones from one experiment and 2 clones from 
the other experiment were sequenced. 
Double-stranded plasmid and single-stranded phage DNA were isolated as 
previously described (Sambrook et al., 1989) from the LECAM-1 cDNA clones. 
The sequence of both strands of bovine LECAM-1 cDNA was determined by the 
dideoxy chain termination method (Sanger et al,, 1977) using T7 DNA 
polymerase (United States Biochemical, Cleveland, OH), primers specific for 
the cloning vectors, and synthesized oligonucleotide primers specific for 
bovine LECAM-1 cDNA. 
Northern Blot Analysis 
Mammary and prescapular lymph nodes and Peyer's patches were removed 
from an adult cow and immediately placed on dry ice. Total RNA was 
recovered by single extraction with an acid guanidinium thiocyanate-phenol-
chloroform mixture (Chomczynski and Sacchi, 1987) and poly(A)'*TlNA isolated 
using oligo dT chromatography (Aviv and Leder, 1972). Ten ug of poly(A)'*TWA 
from these tissues were subjected to electrophoresis in a denaturing agarose 
gel and transferred to a nylon membrane (Nytran, Schleicher and Schuell, 
Keene, NH). Prehybridization was carried out in 50% formamide, 5X 
Denhardt's, 5X SSPE, 0.5% SDS and 0.1 mg/ml salmon sperm DNA for 4 hr at 
42°C. Hybridization was carried out in the same buffer using ^^P-random 
primer labeled (Pharmacia LKB, Piscataway, NJ) bovine LECAM-1 cDNA overnight 
at 42°C. The nylon membrane was washed and exposed to X-ray film at -70°C. 
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The membrane was stripped of LECAM-1 cDNA probe, then reprobed with 32p. 
random primer labeled bovine actin cDNA (kindly provided by Dr. David 
Morris, University of Washington, Seattle, WA) and exposed to X-ray film in 
order to visually determine if comparable amounts of RNA were present in 
each lane. 
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RESULTS 
DNA and predicted amino acid sequence of bovine LECAM-1 
The DNA sequence and predicted amino acid sequence of bovine LECAM-1 
are presented in Figure 1. The 2650 nucleotide cDNA contained one long open 
reading frame of 1110 bases starting at base 129. The 3' end of the cDNA 
terminated in a short poly(A) tail. The cDNA clone from the bovine 
lymphocyte cDNA phagemid library extended from base 272 to base 1327. The 
clone from the bovine lymph node lambda gtlO library extended from base 551 
to base 2650. The sequence for bases 1 to 272 was determined from the five 
RACE produced clones. The multiple rounds of amplification in the RACE 
procedure resulted in an error rate of less than 0.1%. 
The first 38 amino acids of the open reading frame (Figure 1) resembled 
a leader peptide (von Heijne, 1986). This was unusually long for a 
eukaryotic protein but the same length as the leader peptides of human and 
mouse LECAM-1 (Lasky et al., 1989; Siegelman and Weissman, 1989; Siegelman 
et al., 1989). Cleavage of the leader peptide would result in a mature 
protein with a predicted molecular mass of 37.4 kD. Comparison of the 
predicted amino acid sequence of bovine LECAM-1 to human and murine LECAM-1, 
revealed that bovine LECAM-1, like human and murine LECAM-1, had a lectin 
domain, an epidermal growth factor-like domain, and two repeated domains 
similar to complement-binding proteins (Figure 2). Bovine LECAM-1 had an 
overall amino acid identity of 76% and 69% with human and mouse, 
respectively. 
Bovine LECAM-1 had nine putative N-linked glycosylation sites in the 
extracellular domain (amino acids 1-355, Figure 1), eight of which were 
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present in human and/or murine LECAM-1. The transmembrane region (amino 
acids 334-355) had a high level of inter-species identity while the 
cytoplasmic tail of bovine LECAM-1 (amino acids 356-370) was truncated and 
dissimilar when compared to human and murine LECAM-1 (Figure 2). 
Tissue distribution of bovine LECAM-1 
Lymphocytes from mammary lymph nodes, prescapular lymph nodes and 
Peyer's patches were analyzed for surface expression of LECAM-1 with flow 
cytometry (Figure 3). The percentages of DREG-56 positive cells in mammary 
lymph nodes, prescapular lymph nodes and Peyer's patches were 35%, 45%, and 
5%, respectively. Little LECAM-1 mRNA was present in Peyer's patches and 
high levels were seen in mammary and prescapular lymph nodes (Figure 4). 
The size of bovine LECAM-1 mRNA was approximately 3 kb. 
In vitro binding to HEV 
Lymphocytes from mammary and prescapular lymph nodes bound to HEV in 
murine peripheral lymph node sections. Lymphocytes from the mammary lymph 
node had slightly reduced binding to peripheral lymph node HEV compared with 
lymphocytes from the prescapular lymph node. In two separate experiments, 
the numbers of lymphocytes from mammary lymph nodes that bound to HEV was 
81% and 84% of the numbers of lymphocytes from prescapular lymph nodes that 
bound to HEV. This slightly reduced lymphocyte binding was likely due to 
the lower percentage of LECAM-1'*' lymphocytes in mammary lymph node relative 
to prescapular lymph node (Figure 3). 
The antibody DREG-56 reduced the binding of PBL to peripheral node HEV 
to about 25% of the binding seen with PBL that were treated with control 
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antibody (Figure 5). The antibody DREG-56 affected only peripheral homing 
lymphocytes and did not affect the binding of bovine Peyer's patch 
lymphocytes to murine Peyer's patch HEV (Figure 5). 
GAAAGAAA GTAAGCCTTT CTGGGGACAG TGAGTGCAGT CTCCCTGCAC ACCCAGCCTT 58 
GGGCAAGGAT CCAGAGÀCCT GTGGTGCTGA GCTGAGAGGC TGAAGGGCTA CGAAAGGACG 118 
GAGCAAAGCC ATG CTA TGT CCA TGG AAA TGT CAA AAT GCT CAG AGG GGC TTA TGG 173 
Met Leu Cvs Pro Tro Lvs Cvs Gin Asn Ala Gin Are Glv Leu Trn 15 
AAT GTC TTT AAA CTG TGG GTC TGG ATT ATG CTC TGT TGT GAT TTC TTT GCT CAT 227 
Asn Val Phe Lvs Leu Trp Val Trp lie Met Leu Cvs Cvs ASP Phe Phe Ala His 33 
CAT GGC ACC GAT TGC TGG ACT TAG CAT TAT TCC AAA AGA CCC ATG CCC TGG GAA 281 
His Glv Thr ASP CVS Trp Thr Tyr His Tyr Ser Lys Arg Pro Met Pro Trp Glu 51 
AAG GCT AGA GCG TTC TGC AGG GAA AAT TAG ACA GAT TTA GTT GCC ATA CAA AAC 335 
Lys Ala Arg Ala Phe Cys Arg Glu ASN TS& THR Asp Leu Val Ala lie Gin Asn 69 
AAG GGA GAG ATC GAA TAC CTG AAT AAG ACA CTT CCC TTC AGC CGI ACT TAG TAC 389 
Lys Gly Glu Ile Glu Tyr Leu ASN LYS THR Leu Pro Phe Ser Arg Thr Tyr Tyr 87 
TGG ATT GGA ATC CGG AAA GTA GAA GGG GTG TGG ACT TGG GTG GGA AGC AAC AAA 443 
Trp Ile Gly Ile Arg Lys Val Glu Gly Val Trp Thr Trp Val Gly Thr ASN LYS 105 
TCT CTC ACT GAA GAA GCA AAG AAC TGG GGT GCA GGG GAG CCC AAC AAC AGG AAG 497 
SER Leu Thr Glu Glu Ala Lys Asn Trp Gly Ala Gly Glu Pro Asn Asn Arg Lys 123 
AGT AAG GAG GAC TGT GTG GAA ATC TAT ATC AAG AGG AAC AAA GAC TCG GGG AAA 551 
Ser Lys Glu Asp Cys Val Glu Ile Tyr Ile Lys Arg Asn Lys Asp Ser Gly Lys 141 
TGG AAT GAT GAT GCC TGC CAC AAA GCA AAG ACA GCC CTC TGC TAC ACA GCT TCT 605 
Trp Asn Asp Asp Ala Cys His Lys Ala Lys Thr Ala Leu Cys Tyr Thr Ala Ser 159 
TGT AAA CCC TGG TCA TGC AGC GGC CAT GGA CAA TGT GTG GAA GTC ATC AAT AAT 659 
Cys Lys Pro Trp Ser Cys Ser Gly His Gly Gin Cys Val Glu Val Ile Asn ASN 177 
TAC ACC TGC AAC TGT GAT TTG GGG TAC TAC GGG CCT GAG TGT CAG TTC GTG ACT 713 
TYR THR Cys Asn Cys Asp Leu Gly Tyr Tyr Gly Pro Glu Cys Gin Phe Val Thr 195 
CAA TGT GTG CCT TTG GAG GCC CCA AAG CTG GGT ACC ATG GCC TGC ACT CAC CCT 767 
Gin Cys Val Pro Leu Glu Ala Pro Lys Leu Gly Thr Met Ala Cys Thr His Pro 213 
TTG GGG AAC TTC AGC TTC ATG TCG CAG TGT GCC TTC AAC TGC TCC AAG GGA ACA 821 
Leu Gly ASN PHE SER Phe Met Ser Gin Cys Ala Phe ASH CYS SER Lys Gly Thr 231 
GAC ATG ATT GGG GTT GAA GAA ACC ACT TGT GCA CCA TTT GGA AAT TGG TCA TCT 875 
Asp Met Ile Gly Val Glu Glu Thr Thr Cys Ala Pro Phe Gly ASN TRP SER Ser 249 
CCA GAA CCA ACC TGT CGA GTG ATT CAA TGT GAG CCT CTA ACA GAA CCC GAT TTG 929 
Pro Glu Pro Thr Cys Arg Val Ile Gin Cys Glu Pro Leu Thr Glu Pro Asp Leu 267 
GGA ACC ATG GAC TGT AAT CAC CCC CTT GTC GAC TTT GGC TTT TCC TCC ACA TGC 983 
Gly Thr Met Asp Cys Asn His Pro Leu Val Asp Phe Gly Phe Ser Ser Thr Cys 285 
ACC TTC AGT TGT TCA GAA GAA GCT GAG TTA ACT GGG GAG AAA AAA ACT ATC TGT 1037 
Thr Phe Ser Cys Ser Glu Glu Ala Glu Leu Thr Gly Glu Lys Lys Thr Ile Cys 303 
GGA TTG TCT GGA AAT TGG TCC AGC CCT AGT CCA AGA TGT CAA AAA ATA AAC AGG 1091 
Gly Leu Ser Gly ASN TRP SER Ser Pro Ser Pro Arg Cys Gin Lys Ile ASN ARG 321 
Figure 1. Sequence of bovine LECAM-1 cDNA. Nucleotides and predicted amino 
acids are shown. Potential N-linked glycosylation sites are in 
bold and capitalized; the putative leader peptide and 
transmembrane region are underlined 
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ACT ATC TCA ATA AAT GAA GAG AGT GAT TAT AAC CCC CTC TTC ATC CCG GTG GCA 1145 
THR lie Ser lie Asn Glu Glu Ser Asp Tyr Asn Pro Leu Phe lie Pro Val Ala 339 
GTT ATG GTT ACT GCA TTC TCT GGG TTG GCA TTT ATC ATT TGG CTG GCA AGG AGA 1199 
Val Met Val Thr Ala Phe Ser Glv Leu Ala Phe lie lie Tro Leu Ala Arg Arg 357 
TTA AAA AGA AAA AGC AAA AAG GTC TCG GAG AAG CAT GGT TGA TGCATAT 1248 
Leu Lys Arg Lys Ser Lys Lys Val Ser Glu Lys His Gly * 370 
TAAACAACCT GCTCTGAAAG AAAATTCTTC GGATATGAAA GTGTCAGTGG ATCCTTCAAA 1308 
TCCCCTCATG AAGTTTTGCT GGTGGCATCT TCTACACTGA AGAGGAAGTG TGTCTCTCCC 1368 
AGCATATCTG AAGAGTTTTC AACATGACCA GCTGCTCCTT CTGTTCCCGC TTTGCTCCAT 1428 
CTCCCATCCC TCAACTTTCA GCCTGCAGCA GGGAGTTTAA TAACTCAGCC TTTCATTCTT 1488 
TTTTTCCATG GACTACCAAG 'ACCACGGGAA AAAAGGATTA CTATGGAATG TAAATGCACT 1548 
GATTTCATTC TCTCTCTTGA TTCTGGCTTC CAGCTTCAAT TCCATGCTCT ACCTGATGAC 1608 
ATATACTTTT AAATATAGTG AAAATTTGAT ACATATGCAA CTATAGGCTC ACTTTTGTTA 1668 
CAGAACACAC TTTATCTCCC TAGTCCTTCC AGTGTACTGT GGGGGCAATT CATAAAATGA 1728 
TGTTATCCTT GCTTTCCAGC TCAAGTGGTA CTGGGGATCT GCTCCAACTA GGAAAAGTCC 1788 
TATTTGCAGT GTAGCCCCAG CTTCTATCGG AGAAGGCAAT GGCACCTCAC TCCAGTACTC 1848 
TTGTCTGGAA AATCCCATGG ATGGAGGAGC CTGGTGGGCT GCAGTCCTTG GGGTCGCTAA 1908 
GAGTCGGACA TGACTGAGCG ACTTCACTTT CAGTTTTCAC TTTCATGCAT TGGAGAAGGA 1968 
AATGGCAACC CACTCCAGTG TTCTTGCCTG GAGAATCCCA GGGACAGGGG AGCCTGGTGG 2028 
GCTGTGGTCT CTGGGGTCGC ACAGAGTCAG ACACGACTGA AGCGACTTAG CAGCAGTAGC 2088 
AAGTATAATT AGCCTCTATA ATTAGATGCC ATCCCATTTA ACTGCCTCCA GTCGCCTGCC 2148 
TTCTTCAGCC ATCTCTCCTC AGTTGGCTCA TTTCCACATA TAGCAGCTCA TGAGCACCAA 2208 
ACAAAAGAAG AGAAGAAAAA GCCTGCACTG TTGGTTTTAT TTTTTTAATT ATTTTTGGAT 2268 
TGGGGTTTTA GTGTTTCTTT TTTATTAGCC CCATCCAGAT GTTTCTCTTA TGACCACTCA 2328 
TCACTAGAAT GGCAGCTGCA GGCATCTCTT TGATGTCATA CAGAAGAGCT AAAGCAAGTG 2388 
GAAAGAGATG TCTTGACTCA TGGTTGAAAT GTCCCTTCTT CCTCACCCTC AATCCTCTTA 2488 
ACGTATCCGC CTTGATTCTA TCTACTCTTT CTGATTCATC TCAGGCATCC CCCACCCTTG 2508 
CCACTGTTTT CATAACTAAT CCTTAACTAG TCCAAACTGG AAATCTCCCC TTCCTGGCCT 2568 
CCTACTGCAA GATTAGTAAC ATGCATTTTT TGTACTTAAA TATAATTTTT TAAAATAAAA 2628 
AAAAAAAAAA AAAAAAAAAA AA 2650 
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Figure 2. Comparison of predicted amino acid sequences of bovine, human and 
murine LECAM"1. The amino acid sequence (one letter designation) 
for bovine LECAM"1 is shown on the top line. The lectin domain 
is underlined, the epidermal growth factor-like domain is double 
underlined and the two domains similar to complement"binding 
proteins are in bold. Amino acid differences found in human 
(Seigelman and Weissman, 1989) and murine LECAM"1 (Seigelman et 
al., 1989) are shown. Identical amino acids are designated with 
a dash (") 
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CONTROL ANTIBODY DREG-56 
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Figure 3. Expression of LECAM-1 on bovine lymphocytes. Fluorescence of 
bovine lymphocytes incubated with control antibody (left side) 
or DREG-56 (right side) is shown. The lymphocyte populations 
examined are shown under the histograms. The cell count is on 
the vertical axis and the log fluorescence intensity (LFLl) is 
on the horizontal axis 
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Figure 4. Northern blot of LECAM-1 RNA in bovine lymphoid organs. Ten ug 
of poly(A)"hRNA from mammary lymph node (A), prescapular lymph 
node (B), and Peyer's patch (C) were electrophoresed, transferred 
to a nylon membrane, and hybridized with ^^P-labeled bovine 
LECAM-1 cDNA. Actin mRNA levels were determined to ensure 
comparable amounts of RNA were present in each lane. The numbers 
on the left correspond to the position of the ribosomal subunit 
bands 
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Figure 5. The effect of DREG-56 on bovine lymphocyte binding to HEV. The 
percent binding of DREG-56 treated PBL to peripheral node HEV 
(hatched bar) and the percent binding of DREG-56 treated Payer's 
patch lymphocytes to Feyer's patch HEV (open bar), relative to 
lymphocytes treated with control antibody are shown 
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DISCUSSION 
We have been studying lymphocyte homing and lymphocyte homing receptors 
in the bovine (Harp et al., 1988; Bosworth et al., 1991, Bosworth and Harp, 
1991). While the molecular mechanisms controlling lymphocyte homing are 
similar in many species (Wu et al., 1988), cattle differ in some aspects of 
lymphocyte homing. In rodents, and probably other species, the mammary 
lymph node is part of a common mucosal immune system, which includes the 
intestine and respiratory tract (Roux et al., 1977; McDermott and 
Bienenstock, 1979). Rodent lymphocytes sensitized to intestinal antigens 
in the Beyer's patches are able to traffick or home to the mammary gland. 
This allows the mother's immune responses to pathogens in her intestine to 
be transferred, via the homing of lymphocytes sensitized to antigens in the 
intestine to the mammary gland, to colostrum and milk. Thus, the milk and 
colostrum are able to protect the newborn offspring from enteric disease. 
In ruminant species, including cattle, this process is less efficient. 
Bovine mammary lymphocytes tend to home like peripheral lymph node 
lymphocytes (Harp et al., 1988). This suggests that the mammary immune 
system is not part of the common mucosal immune system in ruminants 
(Sheldrake and Husband, 1985; Harp et al., 1988; Harp and Moon, 1987). 
Also, the lymph node venules that are the site of lymphocyte extravasation 
in rodents and humans are lined with cuboidal high-walled endothelium 
(Gowans and Knight, 1964; Jalkanen and Butcher, 1985; Butcher, 1990) but in 
cattle these vessels are lined with relatively flat, low-walled endothelium 
(Harp et al., 1990). In rodents and humans, these endothelial cells are 
esterase positive (Freemont and Jones, 1983; Anderson et al., 1976), in 
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cattle they are esterase negative (Bosworth, personal observations). 
Despite these differences, the control of lymphocyte homing in 
ruminants may involve conserved molecules (Bosworth et al., 1991; Bosworth 
and Harp, 1991). We have previously shown that the bovine peripheral 
lymphocyte homing receptor has lectin-like activity and is functionally 
similar to human and mouse (Bosworth and Harp, 1991). In the present study, 
we identified the bovine equivalent of LECAM-1. The predicted amino acid 
sequence of the molecule was 76% and 69% identical with human and murine 
LECAM-1, respectively. The predicted amino acid structure of bovine LECAM-
1, like human and murine LECAM-1, included a lectin domain, an epidermal 
growth factor-like domain, and two repeated domains similar to complement-
binding proteins. The cytoplasmic tail of bovine LECAM-1 showed little 
similarity with that of human and murine LECAM-1, suggesting that the 
cytoplasmic tail has little involvement in evolutionarily conserved 
functions. These differences in the cytoplasmic tails of LECAM-1 may have 
arisen from different exon usage as the beginning of this area correlates 
with the beginning of the region encoded by exon IX of the human LECAM-1 
gene (Ord et al., 1990). 
Messenger RNA which hybridized with the bovine LECAM-1 cDNA was present 
in higher amounts in peripheral lymph nodes than in Beyer's patches (Figure 
4). The monoclonal antibody DREG-56, which recognizes human LECAM-1 
(Kishimoto et al., 1990), reacted with a molecule present on bovine 
lymphocytes in peripheral, but not mucosal lymphoid tissue. The differences 
in tissue distribution on bovine LECAM-1 surface protein levels were likely 
due to transcriptional regulation. This antibody also blocked the in vitro 
binding of bovine lymphocytes to murine peripheral lymph node HEV, Taken 
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together, the evidence from this and our previous study indicates that 
bovine LECAM-1 is a peripheral lymphocyte homing receptor and is 
structurally and functionally similar to human and murine LECAM-1. 
Differences were seen in the tissue distribution of bovine LECAM-1. 
Few lymphocytes from bovine Peyer's patches expressed LECAM-1, whereas this 
molecule is present on most murine lymphocytes that home to either 
peripheral lymph nodes or Peyer's patches in vivo (Gallatin et al., 1983). 
Possibly, the LECAM-l"*" lymphocytes that home to murine Peyer's patches in 
vivo also express the mucosal homing receptors necessary for homing to 
murine Peyer's patches. An additional possibility is that the LECAM-1 
present on these murine Peyer's patch homing lymphocytes is modified and 
therefore unable to mediate homing to peripheral lymph nodes. Thus in the 
mouse, LECAM-1 is specific in function, but not distribution, to peripheral 
homing cells (Gallatin et al., 1983), whereas in the bovine both function 
and distribution are specific to peripheral homing cells. In this respect, 
the finding of bovine LECAM-1 on mammary lymph node lymphocytes was not 
surprising. In fact, it provides an explanation at the molecular level for 
our previous observations that bovine mammary lymphocytes exhibit homing 
patterns similar to peripheral rather than mucosal lymphocytes (Harp et al. , 
1988). 
In summary, although some of the patterns of lymphocyte homing in the 
bovine differ from those seen in human and mouse, at least one of the 
molecules controlling peripheral homing of lymphocytes appears to be 
conserved in both structure and function between the three species. 
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GENERAL SUMMARY AND DISCUSSION 
In this dissertation, data are presented on lymphocyte molecules that 
control the preferential recirculation or homing of bovine lymphocytes to 
either peripheral lymph nodes or mucosal lymphoid tissue. The cDNA 
sequences and predicted amino acid sequences of bovine CD44 and LECAM-1 
(lectin cell adhesion molecule-1) are similar to those of human and murine 
CD44 and LECAM-1. Bovine LECAM-1, like human and murine LECAM-1, controls 
the homing of lymphocytes to peripheral lymph nodes, but not to mucosal 
lymphoid tissue. Bovine LECAM-1 is expressed at high levels on lymphocytes 
from peripheral lymph nodes (mammary and prescapular lymph nodes), but it 
is expressed at low levels on lymphocytes from mucosal lymphoid tissue 
(Peyer's patch). The expression of high levels of bovine LECAM-1 on 
lymphocytes from both mammary and prescapular lymph nodes provides a 
molecular basis for previous observations that bovine mammary lymph node 
lymphocytes are peripheral homing, not mucosal homing, lymphocytes. The 
differential expression of bovine LECAM-1 on peripheral homing lymphocytes 
(those from peripheral lymph nodes) and mucosal homing lymphocytes (those 
from mucosal lymphoid tissue) may be useful in determining the best method 
of inducing an immune response in a particular tissue. The prevalence of 
LECAM-l"*" lymphocytes in a particular tissue would determine if mucosal or 
peripheral immunization would stimulate lymphocytes that would eventually 
home back to that tissue. It has not been determined if bovine CD44 has a 
role in lymphocyte homing (as does human CD44). The identification of some 
of the molecules involved in bovine lymphocyte homing has increased 
understanding of lymphocyte homing and provides the background for methods 
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that could control the immune response in various tissues by selectively 
regulating peripheral homing or mucosal homing lymphocytes. 
The in vitro HEV assay has been used to characterize the molecules 
controlling lymphocyte homing in a variety of species, including cattle 
(Gallatin et al., 1983; Kishimoto et al., 1990; Streeter et al., 1988a, 
1988b; Bosworth and Harp, 1991; Bosworth and Harp, Part III of this 
dissertation). This in vitro HEV assay reflects the in vivo homing patterns 
of bovine lymphocytes. Bovine mammary and prescapular lymph node 
lymphocytes bind in relatively equal numbers to murine peripheral lymph node 
HEV (Bosworth and Harp, Part III of this dissertation) and bovine mammary 
lymph node lymphocytes tend to home like peripheral lymph node lymphocytes 
in vivo (Harp et al., 1988). Experiments are currently being planned to 
determine if the antibody DREG-56, which recognizes the peripheral 
lymphocyte homing receptor and reduces the binding of bovine lymphocytes to 
murine peripheral lymph node HEV in vitro (Bosworth and Harp, Part III of 
this dissertation), reduces the in vivo homing of bovine lymphocytes to 
peripheral lymph nodes in cattle. The in vitro HEV assay (Bosworth and 
Harp, 1991; Bosworth and Harp, Part III of this dissertation) should prove 
a valuable tool in studying molecules involved in bovine lymphocyte homing 
and should be useful in predicting the in vivo homing patterns of bovine 
lymphocytes from various lymphoid organs. 
While some aspects of bovine lymphocyte homing differ from human and 
mouse, it appears that the peripheral lymphocyte homing receptor, LECAM-1, 
is similar in structure and function in all three species (Bosworth and 
Harp, 1991; Bosworth and Harp, Part III of this dissertation). Carbo­
hydrates that block the binding of human and murine lymphocytes to 
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peripheral lymph node HEV also block the binding of bovine lymphocytes to 
peripheral lymph node HEV in the in vitro HEV assay (Bosworth and Harp, 
1991). This suggests that similar molecules with lectin activity control 
the homing of peripheral lymphocytes in the bovine, human and mouse. The 
presence of a lectin domain has been verified in all three species as the 
predicted amino acid sequences of bovine, human, and murine LECAM-1 contain 
a domain with high homology to number of lectin proteins (Bowen et al., 
1989; Lasky et al., 1989; Siegelman et cl., 1989; Siegelman and Weissman, 
1989; Bosworth and Harp, Part III of this dissertation). 
Lymphocytes from bovine peripheral lymph nodes (mammary and prescapular 
lymph nodes) express higher levels of LECAM-1 than do lymphocytes from 
bovine Beyer's patches (Bosworth and Harp, Part III of this dissertation). 
The presence of similar levels of LECAM-1 on bovine lymphocytes from both 
mammary and prescapular lymph nodes provides a molecular basis for previous 
observations that bovine mammary lymphocytes exhibit homing patterns similar 
to peripheral rather than mucosal lymphocytes (Harp et al., 1988). The 
level of LECAM-1 on lymphocytes from the upper respiratory tract, lower 
respiratory tract, reproductive tract and other organs may be useful in 
determining the homing pattern of bovine lymphocytes. This would be 
extremely useful in determining if a population of lymphocytes are part of 
the common mucosal immune system or part of the peripheral immune system. 
This information would be useful in determining what route of immunization 
(mucosal or peripheral) would likely stimulate an effective immune response 
in these various organs in cattle. Additionally, presence or absence of 
LECAM-1 could be compared to surface antibody isotype present on B cells to 
determine what role lymphocyte homing has in the isotype of antibodies 
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present in various organs in cattle. 
The predicted amino acid sequence of bovine CD44 has high identity with 
that of human and mouse CD44 (Bosworth et al., 1991). Human CD44 has been 
reported to have a role in lymphocyte homing as Hermes-3, a monoclonal 
antibody that reacts with CD44, blocks the binding of human lymphocytes to 
Beyer's patch HEV and polyclonal antiserum to CD44 blocks the binding of 
human lymphocytes to both peripheral lymph node and Peyer's patch HEV (for 
review, see Butcher, 1990). Hermes-3 has no effect on the binding of bovine 
Peyer's patch lymphocytes to murine Peyer's patch HEV (Bosworth, personal 
observations). The role of CD44 in bovine and murine lymphocyte homing is 
not known at this time. Studies using polyclonal antiserum to bovine and 
murine CD44 may be helpful in determining what role, if any, CD44 plays in 
bovine and murine lymphocyte homing. As human CD44 has been reported to be 
involved in a wide variety of cellular adhesion events (Haynes et al., 
1989), the role of bovine CD44 in other adhesion events should also be 
investigated. 
The bovine mucosal lymphocyte homing receptor has not yet been 
identified. Possibly, bovine homologues to the murine mucosal homing 
receptors, LPAM-1 and LPAM-2, control the homing of bovine lymphocytes to 
mucosal lymphoid organs. The in vitro HEV assay will be quite helpful in 
the screening of antibodies to bovine LPAM-1, LPAM-2 or other lymphocyte 
molecules to determine if these molecules are mucosal lymphocyte homing 
receptors in the bovine. 
The recent advances in identifying and characterizing some of the 
molecules controlling lymphocyte homing in the bovine (Bosworth et al., 
1991; Bosworth and Harp, 1991; Bosworth and Harp, Part III of this 
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dissertation) have significantly increased understanding of bovine 
lymphocyte homing. Previously, the majority of data available on bovine 
lymphocyte homing concerned the in vivo homing patterns of lymphocytes 
derived from various locations in the bovine. The identification, 
characterization and sequencing of a bovine peripheral lymphocyte homing 
receptor, bovine LECAM-1 (Bosworth and Harp, 1991; Bosworth and Harp, Part 
III of this dissertation), are significant as these accomplishments provide 
the first insights into molecular control of bovine lymphocyte homing and 
form a solid basis for future studies that will attempt to further 
understand bovine lymphocyte homing. Future research should focus on 
further characterization of the homing receptors and vascular addressins, 
and the in vivo role of these molecules in controlling lymphocyte homing and 
tissue-specific immunity. These studies should further increase 
understanding of lymphocyte homing and lay the groundwork for methods that 
enhance tissue-specific immunity in the bovine and other animals. 
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